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Extracellular secretion is highly desirable in preparative protein production. The bacterium 
Escherichia coli is a commonly used for both laboratory- and industrial- scale biosynthesis of 
proteins, but it lacks many of the pathways for exporting proteins out of cells. This lack of a 
dedicated extracellular secretion system represents a major bottleneck across many 
biotechnology disciplines, in particular the bioprocessing of plant biomass where extracellular 
secretion of cellulase is required. Furthermore, the study and engineering of extracellular 
secretion systems is limited due to a lack of high-throughput screen to identify rare genetic 
conditions that affect secretion activity. Recently, it was discovered in E. coli that the YebF 
protein is secreted efficiently into the supernatant when over expressed, and YebF has been 
employed to carry heterologous proteins into the supernatant via C-terminal genetic fusions. 
Here, we harness the YebF pathway to simultaneously co-secrete active cellulases into the 
culture medium, which enabled non-cellulolytic E. coli cells to utilize and convert cellulose to 
bioenergy products. We also developed a universal approach to study and engineer YebF and 
other extracellular secretion pathways. This high-throughput screening platform was used to 
screen a genome-wide transposon insertion library for the isolation of gene deletions that 
upregulate the secretion of YebF and YebF fusions. We also developed an alternative strategy for 
engineering extracellular secretion systems by way of a genetic selection where the non-
secretory phenotype is lethal. Finally, we describe some of the physiological consequences to the 
bacterial host caused by heterologous protein secretion, in particular an envelope stress response 
that triggers CRISPR RNA-mediated DNA silencing. 
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CHAPTER 1
EXTRACELLULAR SECRETION OF RECOMBINANT PROTEINS IN ESCHERICHIA COLI
1.0 Introduction
! The gram-negative bacterium Escherichia coli is widely used for both laboratory- and 
industrial-scale biosynthesis of proteins. For decades, the strategy for preparative protein 
production in E. coli has been by overexpression of plasmid-encoded proteins for synthesis in the 
cytoplasmic compartment, with the optional step of secretion into the surrounding periplasm. 
Due to a lack of a dedicated extracellular secretion system, most proteins produced in E. coli are 
retained within the cell, either within the cytoplasmic or periplasmic compartment. Preparative 
protein expression from the intracellular space creates strong bottlenecks that reduce yield and 
increase costs associated with their production. For example, the intracellular environment of the 
bacterial cell is highly crowded with macromolecules, often reaching a concentration of 300-400 
mg/mL (Ellis and Hartl, 1996). In this molecularly crowded environment, overexpressed proteins 
can easily misfold, aggregate, and form inclusion bodies, which are difficult to recover 
(Georgiou, 1988; Baneyx and Mujacic, 2004). The intracellular environment also contains at 
least seventy four proteases (Gottesman, 1996), some of which are known affect the stability of 
recombinant proteins of interest (POI) (Baneyx and Mujacic, 2004). Finally, intracellular protein 
synthesis invariably requires costly downstream purification procedures to isolate the POI from 
contaminating cellular debris, such as housekeeping proteins, and also lipopolysaccharides, 
which can be highly immunogenic. 
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! An alternative strategy for the biosynthesis of POI is to target them for export out of 
cells. This would overcome many of the problems associated with intracellular protein synthesis, 
because, unlike the intracellular space, the extracellular space is a highly controlled environment 
with a very low concentration of contaminating cellular components. This is because laboratory 
E. coli strains do not secrete many host proteins to the extracellular space, including proteases. 
Therefore, purification of POI from the culture medium rather than from cells promises increased 
yield, simpler purification, and reduced costs associated with their production. Furthermore, 
certain industrial applications require extracellular secretion of target proteins. For example, 
biosynthesis of POI with cytotoxic activity may only be achieved by extracellular production. 
Also, extracellular secretion is required in consolidated bioprocessing (CBP) systems. CBP 
systems are engineered microbes that are capable of secreting plant cell wall degrading enzymes 
for hydrolysis of plant biomass feedstocks, and also converting the released sugars to energy 
products (see subchapter 1.4 for more information on CBP). Extracellular secretion of enzymes 
is required in these systems because cellulose is not transported into the bacterial cell. 
! Despite all the advantages of extracellular secretion, intracellular protein production has 
been the norm because E. coli lacks a dedicated secretion system to deliver heterologous proteins 
to the extracellular environment. The structural organization of the gram-negative cell means that 
there are two tightly sealed lipid membranes which proteins must traverse if they are to reach the 
extracellular space. All protein biogenesis occurs in the cytoplasmic compartment, and this is 
enclosed by the cytoplasmic or inner membrane, and also the periplasmic compartment, which 
itself is enclosed by the outer membrane. Following synthesis in the cytoplasm, a subpopulation 
of proteins traverse the inner membrane by a well-understood process, either by the Sec or the 
cotranslational signal recognition particle (SRP) system for unfolded or semi-unfolded proteins, 
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or the twin-arginine (Tat) translocation system for fully folded proteins. To be targeted for 
secretion by either of these systems, all proteins must contain a defined N-terminal signal 
sequence.
! Extracellular secretion of proteins is less well-understood. For proteins to reach the 
extracellular space, they can follow one of two general secretory mechanisms (Rêgo et al., 2010). 
The one-step secretory mechanism, such as type I, type III, type IV, and type VI secretion, 
delivers proteins from the cytoplasm directly to the extracellular environment in a single step, 
bypassing an intermediate translocation step in the periplasmic compartment. By contrast, two-
step secretion first delivers the exoprotein to the periplasmic compartment by either the Sec or 
Tat machinery. Once inside the periplasm, the protein can traverse the outer membrane in a 
separate secretion step, such as by the type II secretion system (T2SS), chaperone-usher system 
(CU),  or other mechanism. In two-step secretion processes, the secretory protein undergoes 
residence time within the periplasm. In this manner, the periplasmic intermediate of the secretory 
protein can undergo posttranslational mechanisms exclusive to this compartment, such as 
disulfide bond formation and N-linked glycosylation (Fisher et al., 2011).
! The fact that secretory proteins undergo residence time in the periplasm makes two-step 
secretion pathways attractive for biological and biotechnological contexts that rely on periplasm-
associated posttranslational modifications for activity. For example, many enzymes secreted by 
T2SS contain intramolecular disulfide bonds (Korotkov et al., 2012), and many industrial 
proteins produced in biological hosts require disulfide-bonds for activity, e.g. antibodies. Also, 
many biologics on the market today are glycosylated proteins. E. coli is normally not capable of 
glycosylating proteins, but the N-linked glycosylation machinery from Campylobacter jejuni has 
been functionally transferred to E. coli cells, enabling these cells to selectively glycosylate 
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proteins at defined asparagine residues (Wacker et al., 2002). This protein glycosylation system 
functions natively in the periplasmic compartment (Kelly et al., 2006). Thus, under these 
conditions, glycosylated proteins can only be targeted for extracellular secretion by two-step 
secretion processes. 
1.1 The extracellular proteome of E. coli
! In the vast literature of E. coli biology, there have been, until recently, very few reports 
on extracellular secretion in E. coli K-12. Unlike pathogenic strains, such as enterotoxigenic E. 
coli (ETEC), which rely on secretion systems to disperse virulence factors during host 
colonization (Tauschek et al., 2002), non-pathogenic strains of E. coli secrete very few proteins 
to the extracellular milleau. However, in recent years, a growing body of evidence challenges the 
assumption that E. coli is a poor secretor of proteins. For example, proteomic studies in 
laboratory E. coli strains showed a number of proteins in the supernatant fraction that appeared 
to be secreted by mechanisms that are independent of cell lysis (Rinas and Hoffmann, 2004; 
Nandakumar et al., 2006; Xia et al., 2008). Most of the proteins were outer membrane and 
periplasmic proteins, but also included cytoplasmic proteins (Nandakumar et al., 2006; Xia et al., 
2008). The proteins identified in these studies are of particular interest because they represent a 
potential mechanism for secreting heterologous proteins to the extracellular space. Indeed, two 
outer membrane proteins OmpA, OmpF, and the osmotically inducible protein Y, OsmY, were 
exploited as carriers for secreting a diverse range of proteins, including human and animal 
proteins, and also cellulases (Ni and Chen, 2009; Bokinsky et al., 2011; Kotzsch et al., 2011). 
The mechanisms by which these proteins are secreted into the culture medium is unknown. It is 
possible that outer membrane proteins OmpA and OmpF are shed or released into the 
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extracellular environment as soluble proteins or associated with vesicles. Due to structural and 
biochemical differences, the mechanism for OsmY secretion is likely different (Kotzsch et al., 
2011). 
! One of the earlier studies to demonstrate secretion of heterologous proteins as 
‘passengers’ on extracellular carrier proteins employed a protein called YebF. The YebF protein is 
a small protein (~13 kD) native to E. coli with unknown function, though it has structural 
similarity with the colicin M immunity protein (Cmi), which protects cells from the bacteriolicin 
colicin M (Cma) protein (Usón et al., 2012). Interestingly, there is evidence that YebF 
accumulates at high levels in the supernatant when overexpressed (Zhang et al., 2006). For this 
reason, the YebF protein can potentially be exploited to carry with it heterologous proteins from 
the cytoplasm all the way to the culture medium. In fact, a powerful feature of the YebF system 
is that it tolerates C-terminal fusions with proteins of diverse structural and functional properties. 
Functional enzymes ranging from 15 to 48 kD have been secreted by YebF (Zhang et al., 2006), 
and more recently N-linked glycoprotein domains (Fisher et al., 2011). Therefore, a unique 
feature that the YebF protein has in common with OsmY, OmpA, and OmpF is that it can serve 
as a ‘carrier’ domain for delivering POI to the culture medium without extensive genetic 
manipulation to the E. coli host. These secretion systems can also be called single domain 
secretion systems because they can be genetically fused as single domains to heterologous 
proteins for delivery to the extracellular medium.
! The model for YebF secretion is a two-step process. YebF is secreted into the periplasm 
by the Sec system, and then it is targeted for translocation across the outer membrane by passing 
through the outer membrane porin OmpF, and possibly also OmpC (Fig. 1.1) (Prehna et al., 
2012). The protein OmpC has structural and functional similarity to OmpF, and it appears to be 
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involved, though not required, in YebF outer membrane translocation. It seems likely that YebF 
can be transported through an OmpC/OmpF complex since OmpC has previously been 
demonstrated to form stable heterotrimers with OmpF (Kumar et al., 2010). Finally, a third 
component, OmpX, is also required for YebF secretion, possibly by targeting YebF to the OmpF/
C complex (Fig. 1.1) (Prehna et al., 2012). While outer membrane porins have long been known 
to import bacteriolicins and other molecules (Kleanthous, 2010), this study provides compelling 
evidence that endogenous proteins like YebF can be exported out of cells by outer membrane 
porins. 
Figure 1.1 Model for YebF translocation across the outer membrane. YebF is translocated 
through outer membrane porins OmpF, which forms stable homotrimers, or heterotrimers with 
OmpC. Outer membrane protein OmpX is required for translocation, possibly by directing YebF 
to the OmpF/OmpC complex. Adapted from (Prehna et al., 2012).
Sec machinery
Periplasm
Cytoplasm
Supernatant
YebF
OmpX OmpF/OmpC
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1.2 Type II secretion
!  The studies mentioned thus far indicate that endogenous proteins like YebF, and also 
OsmY, OmpA, and OmpF can be harnessed to serve as ‘carrier’ domains to secrete heterologous 
proteins as ‘passenger’ domains.  An alternative strategy for heterologous protein secretion in E. 
coli expression hosts is to transfer exogenous secretion machinery from other bacteria. Multiple 
studies have demonstrated that exogenous T2SS systems can be expressed in E. coli to secrete 
canonical substrates that pass through these systems in their native hosts. For example, T2SS 
machinery have been functionally transferred from Klebsiella oxytoca (Michaelis et al., 1985) 
and Dickeya dadantii (He et al., 1991), enabling E. coli to secrete pullanase and pectinase, 
respectively. Typically, when expressed in the absence of T2SS machinery, exoproteins localize 
to the periplasm because E. coli lacks the machinery to deliver these proteins across the outer 
membrane (Pugsley, 1993). However, it should be noted that E. coli K-12 has an endogenous and 
functional T2SS encoded by the cryptically-expressed gsp operon (Francetic and Pugsley, 1996). 
These genes are named after the general secretory pathway (GSP) because it is considered to be 
the main terminal branch of the GSP (Francetic and Pugsley, 1996). However, there are two 
bottlenecks that limit the exploitation of this E. coli system to be harnessed for heterologous 
protein secretion. First, while some T2SS can secrete a dozen or more proteins (Kazemi-Pour et 
al., 2004), the only known substrate to be secreted by the gsp T2SS is a chitinase encoded by 
chiA. Second, expression of gsp T2SS is negatively controlled by the universal repressor protein 
H-NS. Thus, the gsp operon is not expressed under laboratory conditions. Only when H-NS 
protein is removed and the gsp operon is overexpressed can ChiA be secreted in detectable 
amounts (Francetic et al., 2000a). 
7
! Like the YebF secretion system, T2SS is a two-step secretion process; substrates targeted 
for T2SS enter the periplasm by Sec or Tat machinery, and then traverse the outer membrane by 
the T2SS assembly. Proteins translocated through the outer membrane are fully folded and often 
contain intramolecular disulfide bonds (Korotkov et al., 2012). The T2SS is encoded by 12-15 
genes, usually arranged in an operon (Korotkov et al., 2012). These genes are conserved in many 
gram-negative organisms, and they encode a macromolecular complex that spans the inner 
membrane, periplasm, and outer membrane. The inner membrane platform contains an ATPase 
that provides energy for T2SS-mediated translocation. In this working model of T2SS, a 
filamentous structure directly interacts with exoproteins and polymerizes in a pilus-like assembly 
to ‘push’ exoproteins through an outer membrane porin encoded by E. coli gspD (Korotkov et 
al., 2012). 
! A long-standing question in T2SS biology is how exoproteins are recognized by the T2SS 
assembly. No linear amino acid signal sequence has been identified, and one possibility is that 
the signal sequence is encoded within the three-dimensional confirmation of the exoprotein 
(Korotkov et al., 2012). Protein domain deletion experiments identified a conserved PDZ domain 
in the D. dadantii OutC protein (E. coli GspC) that is required for secretion activity and also 
appears to interact directly with exoproteins (Bouley et al., 2001), indicating that this motif may 
be at least partly responsible for determining substrate specificity. Furthermore, OutC, and also 
OutD (E. coli GspD), are the only proteins of the out operon that cannot be complemented by 
homologs from the closely related organism Pectobacterium carotovorum, suggesting these two 
proteins are the ‘gatekeepers’ of substrate specificity among different species (Lindeberg et al., 
1996). These unresolved aspects may limit the exploitation of T2SS for heterologous protein 
secretion.
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! Many plant and animal pathogens rely on T2SS for host invasion. Some toxins of human 
pathogens are secreted by T2SS, like the cholera toxin (CT) of Vibro cholerea (Sandkvist et al., 
1997) and the heat-labile enterotoxin (LT) of enterotoxigenic E. coli (ETEC) (Tauschek et al., 
2002). The T2SS also mediates the secretion of enzymes with highly degradative effects on plant 
and animal tissues, such as phospholipases, proteases, and lipolytic enzymes secreted by 
Psuedomonas aeurginosa, the causative agent of cystic fibrosis (Jyot et al., 2011). This is 
particularly true for plant pathogens which use T2SS to secrete a broad range of plant cell wall 
degrading enzymes (PCWDEs) (DeBoy et al., 2008),(Lindeberg, 1992), including pectinases and 
cellulases (Table 1.2). This feature makes T2SS a potentially powerful method for secreting 
cellulase enzymes and other PCWDEs in engineered CBP microbes. This speculation is further 
supported by the recent observation that T2SS is required for Cellvibrio japonicus to grow on 
model pretreated plant biomass feedstocks, like corn stover and switchgrass (Gardner and 
Keating, 2010). Furthermore, T2SS from the phytopathogen D. dadantii, which secretes at least 
13 PCWDEs via this system (Kazemi-Pour et al., 2004), has been functionally transferred to E. 
coli cells (He et al., 1991). These two studies may be useful for future studies in engineering 
CBP microbes with T2SS machinery.
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Name of bacterium Known effectors
Pectobacterium carotovorum Pectate lyases
Cellulase/endoglucanase
Polygalacturonase
Dickeya dadantii Pectate lyases
Cellulase/endoglucanase
Polygalacturonase
Pectin acetylesterase
Pectin methylesterase
Rhamnogalacturonate lyase
FaeD esterase
Ralstonia solancearum Polygalacturonase
Cellulase/endoglucanase
Pectin methyl esterase
Cellobiohydrolase
Xanthomonas campestris Polygalacturonase
Cellulase/endoglucanase
Proteases
Alpha-amylase
Xanthomonas orzae Xylanase
Celulase/endoglucanase
Putative cysteine protease
Putative cellobiohydrolase
Lipase/esterase
Cellvibrio japonicus Cellulases/endoglucanase
Beta-glucosidase
Cellobiohydrolase
Table 1.2 Type II secretion system-secreted protein from phytopathogenic bacteria. Plant 
pathogens rely on the T2SS to secrete PCWDEs. Many PCWDEs are virulence factors that help 
pathogens colonize their host, causing diseases in plants such as bacterial soft rot by Dickeya 
species and bacterial wilt by R. solanacearum. Adapted from (Sonti, 2005).
1.3 Type III secretion
! Like the T2SS, the type III secretion system (T3SS) is conserved in many gram-negative 
bacteria, and it is used by plant and animal pathogens to secrete virulence factors. But unlike the 
T2SS, T3SS is a one-step secretion mechanism that is capable of delivering proteins from the 
bacterial cytoplasm directly to the extracellular medium, or into the cytosol of plant and animal 
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cells, thereby bypassing intermediate residence of the exoprotein within the periplasm. (Cornelis, 
2006). The injecting of effector proteins into eukaryotic cells is mediated by an injectosome, 
which is a highly complex and highly regulated macromolecular nanomachine composed of 
about 25 proteins (Hodgkinson et al., 2009). These proteins assemble to form an ultrastructure 
protruding from the cellular envelope that resembles a molecular ‘syringe,’ and these proteins are 
genetically, morphologically, and functionally related to flagellar basal bodies (Blocker et al., 
2003).
! The T3SS has advantages over other secretory mechanisms in certain contexts within 
biotechnology. First, the unique ability of T3SS to inject effector proteins in eukaryotic cells can 
been exploited as a novel approach for targeting therapeutics into host cells, and this has already 
be done in Salmonella and Yersinia species (Rüssmann et al., 1998; Boyd et al., 2000; Konjufca 
et al., 2006). In principle, the same approach could be used to treat diseases in humans. For 
instance, the non-pathogenic E. coli strain Nissle 1917 has been widely used as a probiotic agent 
to treat inflammation and infection of the intestine (Lodinová-Žádníková et al., 1998), and has 
recently been used to deliver therapeutic molecules by surface display (Westendorf et al., 2005), 
and by the Hly type I secretory apparatus (Rao et al., 2005). Thus, engineering E. coli Nissle 
1917 with T3SS may one day be a powerful strategy for drug delivery. Although E. coli K-12 
and Nissle are not known to encode a T3SS, a cloned T3SS called Hrp from Dickeya dadantii 
has been shown to function in E. coli cells (Ham et al., 1998).
! A second advantage of T3SS over T2SS is that the N-terminal signal tag, chaperone, and 
chaperone binding domain for proteins secreted by the T3SS have been identified (Galán and 
Collmer, 1999), and this information has been used to secrete recombinant proteins via this 
pathway (Widmaier et al., 2009). Despite these advantages, a limitation to the T3SS is that the 
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exoproteins are delivered from the cytoplasm to the extracellular space in one step, thus proteins 
that depend on periplasm-associated posttranslational modifications, like glycosylation and 
disulfide bond formation, cannot be exported by the T3SS.
1.4 Consolidated bioprocessing
! Cellulose is the most abundant carbon compound on earth and it represents an untapped 
reservoir for bioenergy. Currently, biochemical processing of plant biomass requires the addition 
of costly cellulolytic enzymes to overcome the recalcitrant nature of cellulose (Fig. 1.4A). One 
strategy for lowering costs is to engineer microbe-based production systems for the synthesis and 
extracellular secretion of cellulases. These microbes can in principle be engineered for 
consolidated bioprocessing (CBP), whereby the secretion of the plant cell wall degrading 
enzymes and fermentation of released sugars to target energy products like ethanol occurs in a 
single host organism (Fig. 1.4A). Sacchromyces cerevisiae is well-known ethanogen, but gram-
negative bacteria, such as Zymomonas mobilis, are also capable of commerical-scale ethanol 
production (Rogers et al., 2007). E. coli has also been engineered for efficient ethanol production 
(Jarboe et al., 2007), and other bioenergy products like 1,2-propanediol (Altaras and Cameron, 
1999), butanol, pinene, and fatty acid ethyl ester (Bokinsky et al., 2011). A major challenge in 
the development of gram-negative bacteria for CBP is the lack of a robust secretion system for 
targeting PCWDEs capable of degrading plant biomass feedstocks. Ideally, this secretion system 
would be able to recognize and secrete heterologous enzymes engineered for optimal 
performance on industrially relevant plant biomass feedstocks. A closely related organism 
Cellvibrio japonicus is well known for degrading plants (DeBoy et al., 2008), and it can grow on 
industrial feedstocks like pretreated corn stover and switch grass (Gardner and Keating, 2010). 
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Thus, one strategy is to metabolically engineer organisms already capable of plant biomass 
degradation, like C. japonicus, with metabolic pathways for converting the released sugars to 
target chemical products. An alternative strategy is to engineer dedicated secretion platforms for 
secretion of cellulases in E. coli, so that these cells have the ability to use biomass feedstocks for 
production of biofuels. This approach was taken in a recent study, which relied on the OsmY 
secretion system to secrete cellulases and convert biomass feedstocks to three model biofuels 
(Fig. 1.4B) (Bokinsky et al., 2011).
Figure 1.4 Consolidated bioprocessing. In consolidated bioprocessing systems, enzyme 
generation, biomass hydrolysis, and biofuel production are performed in a single step. Microbes 
capable of consolidated bioprocessing secrete cellulases and convert released sugars to target 
bioenergy products. Cellulases (circles) synthesized by the CBP microbe release monsaccharides 
(rectangles) from plant biomass, which can be fermented by the CBP microbe to to target energy 
products, such as ethanol, isobutanol, or fatty alcohols. Adapted from (Bokinsky et al., 2011).
OH
OH
OH(  )
n
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CHAPTER 2
PRODUCTION OF EXTRACELLULAR N-LINKED GLYCOPROTEINS IN ESCHERICHIA 
COLI 1
2.0 Introduction
 Given the recent success in exporting recombinant proteins via the YebF pathway (Zhang 
et al., 2006), we investigated the ability of this system to secrete therapeutically and industrially 
relevant biomolecules. Many therapeutic biologics on the market today are glycosylated proteins. 
Asparagine-linked (N-linked) protein glycosylation is essential and conserved in eukaryotic 
organisms. It is the most prevalent of all posttranslational protein modifications, affecting nearly 
70% of the eukaryotic proteome (Apweiler et al., 1999). The attachment of N-glycans to 
eukaryotic secretory and membrane proteins can influence their folding and stability, 
oligomerization, resistance to proteolysis, sorting, and transport (Helenius and Aebi, 2001; 
2004). N-linked glycosylation occurs in the endoplasmic reticulum (ER) and involves the 
assembly of glycans on a lipid carrier in the ER membrane followed by transfer to specific 
asparagine residues of target polypeptides. Initially, it was believed that N-linked glycosylation 
was unique to eukaryotes. However, N-glycoproteins have now been described for all domains of 
life, including archaea and more recently bacteria, of which the best-characterized example is the 
human gastroenteric pathogen Campylobacter jejuni (Szymanski and Wren, 2005). In C. jejuni, 
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1Adapted with permission from:
Fisher A. C., C. H. Haitjema, C. Guarino, E. Celik, C. E. Endicott, C. A. Reading, J. H. Merritt, A. C. Ptak, S. 
Zhang, and M. P. DeLisa. 2011. Production of secretory and extracellular N-linked glycoproteins in Escherichia coli. 
Appl Environ Microbiol, 2010th ed. 77:871–881.
the genes for this pathway comprise a 17-kb locus named pgl for protein glycosylation 
(Szymanski et al., 1999). To date, more than 40 periplasmic and membrane glycoproteins have 
been identified in C. jejuni (Young et al., 2002; Kowarik et al., 2006b), and most of these bind to 
the N-acetyl galactosamine (GalNAc)-specific lectin soybean agglutinin (SBA) (39). Mass 
spectrometry and nuclear magnetic resonance (NMR) studies revealed that the N-linked glycan is 
GlcGalNAc5 Bac, where Bac is bacillosamine (2,4-diacetamido- 2,4,6-trideoxyglucose) (Young 
et al., 2002). This branched heptasaccharide is synthesized by sequential addition of nucleotide-
activated sugars on the lipid carrier undecaprenyl pyrophosphate on the cytoplasmic face of the 
inner membrane (Feldman et al., 2005). Once assembled, the lipid-linked heptasaccharide is 
flipped across the membrane by the putative ATP-binding cassette (ABC) transporter PglK 
(Alaimo et al., 2006; Kelly et al., 2006). Transfer of the heptasaccharide to periplasmic substrate 
proteins is catalyzed by an oligosaccharyltransferase (OST) called PglB, a single integral 
membrane protein with significant sequence similarity to the catalytic subunit of the eukaryotic 
OST STT3 (Young et al., 2002). PglB attaches the heptasaccharide to asparagine in the motif D/
E-X1-N-X2- S/T (where X1 and X2 are any residues except proline), a sequon similar to that of 
eukaryotes (Kowarik et al., 2006b).
Recently, Wacker and coworkers transferred the entire C. jejuni pgl locus into 
Escherichia coli, conferring upon these cells the ability to N-glycosylate proteins (Wacker et al., 
2002). Native C. jejuni glycoproteins such as Peb3 and AcrA, which are localized to the 
periplasm by the Sec pathway, can be N-glycosylated in glycosylation-competent E. coli (Wacker 
et al., 2002). AcrA can also become N-glycosylated when transported via the twin-arginine 
translocation (Tat) pathway, which is well known for its ability to export folded proteins across 
the inner membrane (Kowarik et al., 2006a). In addition to periplasmic proteins, some native C. 
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jejuni N-glycoproteins are predicted to be integral membrane proteins based on bioinformatic 
analysis (Kowarik et al., 2006b). Collectively, these earlier studies suggest that the C. jejuni N-
linked glycosylation machinery is compatible with diverse secretory mechanisms and can 
tolerate an array of structures ranging from unfolded polypeptides to completely folded (albeit 
highly flexible and solvent-exposed) protein domains. However, the influence of membrane 
translocation and folding of acceptor proteins on bacterial N-linked glycosylation has not been 
thoroughly addressed. It is also not known whether proteins destined for locations beyond the 
periplasm, such as the outer membrane or the extracellular medium, are compatible with N-
linked glycosylation.
Therefore, the goal of this study was to investigate the extent to which different secretory 
and extracellular protein substrates could be N-glycosylated in E. coli cells carrying the pgl 
locus. To address this issue, we developed a genetically encoded N-glycan acceptor peptide tag 
(GT) that can be appended terminally or inserted at internal locations of recombinant proteins. 
Numerous recombinant proteins modified with the GT were reliably glycosylated in E. coli 
strains expressing the pgl genes. When the GT was used in combination with proteins targeted to 
the periplasm by different export pathways (e.g., Sec, signal recognition particle [SRP], or Tat), 
we observed a clear difference in the glycosylation patterns on these proteins depending on their 
mode of inner membrane translocation. In all cases tested, N-glycan attachment via the GT did 
not have any measurable effect on the protein’s activity. Finally, we show that proteins targeted 
to different locations, including the periplasm, the outer membrane, membrane vesicles, and the 
extracellular medium, were amenable to N-linked glycosylation.
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2.1 Extracellular production of extracellular N-linked glycoproteins in E. coli
! Since vesicle-mediated secretion was compatible with N-linked glycosylation (Fisher et 
al., 2011), we next determined whether proteins glycosylated in the periplasm could be directed 
for secretion across the outer membrane and into the culture medium. We chose the E. coli YebF 
protein as a carrier to target proteins for extracellular secretion. YebF is a small protein (10.8 kDa 
in the mature form) that is transported into the bacterial periplasm by the Sec translocase and 
then delivered across the outer membrane by an unknown mechanism (Zhang et al., 2006). YebF 
can carry C-terminal fusion partners into the culture medium at high levels (Zhang et al., 2006). 
To determine if N-glycosylated derivatives of YebF could be secreted into the culture 
supernatant, we created a YebF-GT chimera in plasmid pTrc99A. Extracellular YebF-GT was 
secreted from both pgl and pglmut cells and reacted readily with anti-His antibodies (Fig. 2.1a). 
The secreted YebF-GT from pgl cells, but not pglmut cells, also reacted with hR6P (Fig. 2.1a). 
As expected, YebF-GT lacking its native Sec signal peptide (ΔspYebF-GT) was not detected in 
the supernatant fraction (Fig. 2.1a). 
! To determine if YebF could carry recombinant glycoproteins into the supernatant, we 
translationally fused ΔspMBP-GT to the C terminus of YebF. The YebF-ΔspMBP-GT fusion was 
secreted into the culture medium by both pgl and pglmut cells, but only the fusion protein 
secreted from pgl cells was observed to react with hR6P (Fig. 2.1b). For secretion controls, we 
tested ΔspYebF-ΔspMBP-GT, which lacks an N-terminal export signal, and spYebF-ΔspMBP-
GT, which modifies ΔspMBP-GT with only the native YebF signal peptide and does not include 
the mature YebF domain. As expected, ΔspYebF-ΔspMBP-GT was not localized in the 
periplasm or the supernatant (Fig. 2.1b) owing to the absence of an N-terminal signal peptide. 
The spYebF-ΔspMBP-GT construct was exported into the periplasm of glycosylation-competent 
17
cells, where it became glycosylated; however, only a faint band corresponding to the fusion was 
detected in the culture medium (Fig. 2.1b), indicating that the YebF protein is required for 
extracellular secretion of the fusion proteins tested here.
Figure 2.1 Secretion of N-glycoproteins in the culture supernatant. (a) The GT is comprised 
of four consecutive D-X1-N-X2-T sequons that are efficiently glycosylated in bacteria.
(b) Western blot analysis of YebF-GT and ∆spYebF-GT in the culture supernatant of MC4100 
cells. (c) Western blot analysis of ∆spMBP-GT fused to full-length YebF, ∆spYebF, and the 
spYebF signal peptide as indicated. The arrowhead indicates the YebF– ∆spMBP-GT degradation 
product. The supernatant (sup) and periplasmic (per) fractions were probed with anti-His 
antibodies or hR6P serum as indicated. Proteins were expressed in cells carrying pACYCpgl (+) 
or pACYCpglmut (-). All proteins were Ni-NTA affinity purified from the supernatant and 
periplasmic fractions. The same amount of protein was loaded in each lane. Blots were probed 
with anti-His or hR6P antibodies as indicated.
a
b
c
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2.2 Discussion
! In this study, we have demonstrated the N-linked glycosylation of diverse secretory and 
extracellular protein substrates expressed in E. coli cells carrying the C. jejuni pgl locus, thereby 
expanding the N-linked glycome of recombinant E. coli. This was achieved by the development 
of a genetically encoded glycosylation tag that promoted reliable N-linked glycosylation when 
introduced at the termini or at internal locations of recombinant proteins. Using this tag, proteins 
targeted to different locations, including the periplasm (via the Sec, SRP, and Tat pathways), the 
outer membrane, membrane vesicles, and the extracellular medium, were efficiently 
glycosylated. To our knowledge, this is the first report that the C. jejuni N-glycosylation 
machinery is compatible with cotranslational (i.e., SRP), outer membrane, and extracellular 
protein targeting mechanisms in E. coli.
! These results also illuminate key mechanistic similarities and differences between 
prokaryotic and eukaryotic N-linked glycosylation. In eukaryotes, N-glycan addition occurs on 
polypeptides as they emerge through the translocation pore, a process called cotranslocational 
glycosylation. In this scenario, acceptor proteins are translocated into the ER in an extended 
conformation, and the OST is thought to recognize polypeptides in an unfolded state (Whitley et 
al., 1996; Chen and Helenius, 2000). In the bacterial system, translocation and glycosylation are 
apparently uncoupled, and glycosylation sites are located in flexible parts of folded proteins 
(Kowarik et al., 2006a). Indeed, we found that protein substrates exported in a folded 
conformation by the Tat pathway were N-glycosylated in the periplasm, consistent with recent 
findings of Kowarik and coworkers (Kowarik et al., 2006a), who also showed that completely 
folded proteins can be modified by PglB in vivo. We also found that the bacterial OST can 
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accommodate unfolded proteins, as well as folded proteins, as substrates. For example, outer 
membrane proteins, which are exported by the Sec pathway and maintained in an unfolded 
conformation until insertion in the outer membrane (Bos et al., 2007), were efficiently 
glycosylated by PglB. Presumably, glycosylation occurred in the periplasm prior to outer 
membrane integration, when folding was still incomplete. Likewise, the vesicle-mediated and 
extracellular secretion mechanisms investigated here, although poorly understood, are likely to 
involve unfolded periplasmic intermediates that are amenable to glycosylation by PglB. Taken 
together, our results reveal PglB to be a very versatile enzyme based on its ability to glycosylate 
both folded and unfolded substrates. While the glycosylation of Tat substrates here and elsewhere 
(Kowarik et al., 2006a) clearly indicates that PglB attaches N-glycans posttranslationally, our 
results do not exclude the possibility that PglB glycosylates some substrates in a cotranslational 
manner. In support of this possibility, we observed that proteins targeted to the SRP pathway 
were competent for glycosylation, and we are now determining whether these proteins undergo 
cotranslational glycosylation. Such a coupling between translocation and glycosylation would 
have important consequences for bacterial glycoengineering because potential acceptor sites 
would not be confined to locally flexible structures but instead could be located in structured 
domains that become glycosylated prior to folding.
! An important outcome of our studies is the demonstration that a simple glycosylation tag 
is sufficient to promote covalent attachment of multiple glycans to a single protein carrier. We 
anticipate that this tag will be useful in a number of important areas related to glycobiology and 
glycomedicine. For example, the GT could be used to express and isolate carrier proteins that are 
hyper-glycosylated with a multiplicity of homogeneous glycans. Such hyper-glycosylated 
proteins could then be used as features on carbohydrate microarrays (so-called glycoarrays), 
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which are currently very challenging to fabricate due in large part to difficulties associated with 
the synthesis and isolation of sufficient quantities of naturally occurring oligosaccharides 
(Laurent et al., 2008). Glycan diversity could be “genetically encoded” by expression of different 
glycosyltransferases to control the specific glycoform, and covalent transfer onto target proteins 
could be achieved using PglB, which is relatively promiscuous in its choice of both 
oligosaccharide (Feldman et al., 2005) and protein (Fig. 3) substrates. Another potential use of 
the GT is in the development of therapeutic glycoprotein conjugates. For example, bacterial 
polysaccharides conjugated to proteins have proven effective as vaccines, as evidenced by the 
Haemophilus influenzae type b conjugate vaccine (Verez-Bencomo et al., 2004). By expanding 
the spectrum of recombinant protein carriers that can be N glycosylated via fusion to the GT, 
more-complex conjugate vaccine candidates may be developed. For example, multiple doses of 
H. influenzae type b capsular polysaccharide conjugate vaccines are required to induce protective 
antibody responses in infants. When conjugated to the meningococcal outer membrane protein 
(OMPC), protective antibody responses are induced after a single dose (Pérez-Melgosa et al., 
2001). A recombinant glycosylation tag could allow for N-linked glycosylation of optimized 
protein carriers in E. coli. Even MBP could serve as a useful carrier for glycoconjugate vaccines 
since (i) it can be engineered to carry far more glycans than most naturally occurring 
glycoproteins (Fig. 1b) (Ben-Dor et al., 2004) and (ii) it has demonstrated immunostimulatory 
properties (Fernandez et al., 2007). A final application for the GT is in the development of 
genetic tools for analyzing glycosylation phenotypes, which at present are severely lacking. A 
recombinant peptide tag allows glycosylation of proteins that may be amenable to extracellular 
display (Smith, 1985; Francisco and Georgiou, 1994) and/or two-hybrid systems (Joung et al., 
2000) for the isolation of specific N-glycans. Further, a GT could be fused to a permissive site in 
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a binding protein or enzyme such that glycosylation modulates the activity of the enzyme. Such a 
scheme would allow for genetic selection or screening dependent on functional N-linked 
glycosylation. It is our hope that the glycosylation tag strategy presented here allows for a higher 
level of sophistication and throughput in the emerging field of glycoengineering and opens the 
door to bacterial synthesis of a wide array of recombinant glycoprotein conjugates.
2.3 Materials and methods
2.3.1 Bacterial strains and growth conditions
! E. coli strain DH5α was used for cloning of plasmids. For YebF-mediated secretion 
studies, strain MC4100 was used because this strain exhibits the least leakage of maltose-binding 
protein (MBP) of 15 common E. coli strains tested (Zhang et al., 2006), and a derivative strain 
showed no leakage of MBP during its early growth stage (Francetic et al., 2000b). Overnight E. 
coli cultures were diluted in fresh Luria-Bertani broth (LB) supplemented with antibiotics and 
0.2% glucose and grown at 30°C or 37°C. At mid-log phase (optical density at 600 nm [OD600], 
∼0.5), the medium was changed to glucose-free LB containing antibiotics and protein expression 
was induced with either 100 μM isopropyl-β-D-thiogalactopyranoside (IPTG) for pTrc99A-
based expression vectors or 0.2% arabinose for pBAD-based expression vectors. Induction was 
at 25°C or 30°C for up to 24 h. Antibiotics were used at the following concentrations: 100 μg/ml 
ampicillin (Amp), 25 μg/ml chloramphenicol (Cm), and 50 μg/ml Kan.
2.3.2 Plasmid construction
! All YebF plasmids were derivatives of pTrc99A. For these, E. coli yebF was PCR 
amplified and cloned between SacI and XbaI in pTrc99A. Controls were similarly constructed by 
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cloning either the YebF N-terminal signal peptide (spYebF) or the mature domain of YebF 
lacking the N-terminal signal peptide (ΔspYebF) between SacI and XbaI in pTrc99A. The GT or 
MBP-GT fusion was then added to each YebF vector between the XbaI and SalI sites. Lastly, a 
6×-His affinity tag was inserted between the SalI and HindIII sites. The sequences of all plasmids 
constructed in this study were confirmed by DNA sequencing.
2.3.3 Subcellular fractionation and protein purification
! To isolate intracellular glycoproteins, equal numbers of cells were pelleted by 
centrifugation at 5,000 × g for 15 min at 4°C, resuspended in 1 ml lysis buffer supplemented 
with 1% (vol/vol) Triton X-100 and 1 mg/ml lysozyme, and incubated on ice for 30 min. Cells 
were then sonicated 4 times for 30 s with a 1-min rest between each sonication. The sonicated 
cells were spun down at 10,000 × g at 4°C for 20 min, and the supernatants were collected. For 
preparation of periplasmic and culture supernatant fractions, equal numbers of cells were 
harvested by centrifugation at 5,000 × g for 15 min at 4°C. The supernatant fraction was 
subjected to 0.2-μm filtration and then concentrated with an Amicon Ultra centrifugal filter from 
Millipore. The cell pellet was washed and then subjected to subcellular fractionation into 
periplasmic and cytoplasmic fractions using the ice-cold osmotic-shock procedure as described 
elsewhere (DeLisa et al., 2003; Kim et al., 2005).  All 6×-His-tagged proteins were purified using 
Ni-nitrilotriacetic acid (NTA) spin columns (Qiagen) according to the manufacturer's instructions 
(Ni-NTA spin kit; Qiagen) under native conditions. Fc domains were purified using NAb protein 
A/G spin columns according to the manufacturer's instructions (Thermo Scientific).
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2.3.4 Protein analysis
! Proteins were separated with SDS-polyacrylamide gels (Bio-Rad), and Western blotting 
was performed as described previously (DeLisa et al., 2003). Briefly, proteins were transferred 
onto polyvinylidene fluoride (PVDF) membranes, and membranes were probed with one of the 
following: anti-MBP antibodies conjugated with horseradish peroxidase (HRP) (New England 
Biolabs), anti-6×-His antibodies conjugated to HRP,  and hR6P antiserum, which is specific for 
the C. jejuni heptasaccharide (kindly provided by Markus Aebi). In the case of hR6P antiserum, 
anti-rabbit IgG-HRP (Promega) was used as the secondary antibody.
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CHAPTER 3
A UNIVERSAL APPROACH FOR ENGINEERING EXTRACELLULAR SECRETION 
PATHWAYS
3.0 Introduction
! There is unprecedented interest in converting plant biomass into fermentable sugars for 
the production of bioenergy products. Currently, the biochemical processing of plant biomass 
requires the addition of costly cellulolytic enzymes due to the complex and crystalline nature of 
lignocellulose, the major component of plant biomass (Wilson, 2009). An alternative strategy is 
consolidated bioprocessing (CBP) whereby by a single organism secretes plant cell wall 
degrading enzymes and simultaneously ferments the released sugars into fuel products. A CBP 
platform could dramatically reduce production costs associated with cellulosic biofuels (Lynd et 
al., 2008). E. coli remains the most robust host for recombinant protein productions and can be 
engineered for efficient production of ethanol (Jarboe et al., 2007), but it lacks a dedicated 
extracellular secretion system. Extracellular secretion is a requirement for degradation of plant 
cell walls, because cellulose is intractable and not transported into the microbial cell. Many 
phytopathogenic bacteria rely on large macromolecular complexes called type II secretion 
systems T2SS to secrete plant cell wall degrading enzymes (Sonti, 2005). However, there are two 
major limitations that could prevent T2SS for use in CBP platform. First, the secretion signal for 
targeting heterologous proteins to this pathway has not been identified and so T2SS can only 
recognize cognate exoproteins (Korotkov et al., 2012). Second, there appears to be a stringent 
species specificity associated with T2SS that prevents these systems from secreting the proteins 
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of even closely related organisms (Lindeberg et al., 1996). An alternative to T2SS is a single-
domain secretion system called YebF that can efficiently carry recombinant proteins into the 
extracellular environment (Zhang et al., 2006; Fisher et al., 2011). It was recently discovered that 
YebF and YebF-fusions can be glycosylated by engineered strains of E. coli (Fisher et al., 2011). 
This is an important observation as glycosylation affects the properties of many industrial 
enzymes including cellulases (Jeoh et al., 2008). In this report, we engineered E. coli K-12 for 
robust extracellular secretion of a recombinant cellulolytic cocktail via the YebF secretion 
pathway. The enzymes were rationally selected from phytopathogenic bacterium, Cellvibrio 
japonicus, which is well known for degrading plant biomass (DeBoy et al., 2008; Gardner and 
Keating, 2010). Secretion of these cellulases conferred the ability of non-cellulolytic E. coli to 
grow on carboxymethyl cellulose (CMC) as a sole carbon source. Finally, to increase cellulase 
secretion titers, we screened a transposon-insertion library that enhance extracellular 
accumulation of YebF. We did this by developing high-throughput screening technology for 
extracellular secretion based on the biarsenical FlAsH-EDT2 dye. The mutants isolated in this 
study exhibited enhanced export of YebF and YebF-cellulase fusions to the extracellular space. 
As a result, we were able to show that these strains were able to hydrolyze and grow on cellulose 
more robustly than the parental strain.
3.1 Co-secretion of a cellulolytic cocktail confers growth on cellulose.
! E. coli lacks two key components necessary for a CBP platform, (i) cellulolytic activity 
encoded by cellulases and hemicellulases for hydrolysis of lignocellulose into monosaccharides 
that can imported and metabolized by the cell, and (ii) a secretion platform for delivering these 
enzymes to the extracellular environment. To address the first issue, we rationally selected four 
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enzymes that we predicted would represent the basic set of cellulolytic activity to efficiently 
degrade cellulosic and hemicellulosic substrates. The enzymes, encoded in Cellvibrio japonicus, 
a gram-negative bacterium known for efficient plant cell wall degradation (DeBoy et al., 2008), 
include Cel3A, Cel5B, Cel6A, and Cel9A, a predicted beta-glucosidase, endoglucanase, 
cellobiohydrolase, and processive endoglucanase, respectively. While C. japonicus requires 
T2SS for growth on cellulose (Gardner and Keating, 2010), it is not currently known if these 
enzymes are secreted by the T2SS. Thus, to target these proteins for extracellular secretion, we 
fused each enzyme to the C-terminus of YebF, a protein known for carrying a broad range of 
proteins to the extracellular environment (Zhang et al., 2006). The sequence of each enzyme was 
codon optimized for expression in E. coli and cloned into an expression vector. A C-terminal 6H 
affinity tag was included for downstream purification and immunoblot analysis. When these 
plasmids were expressed in wild-type BW25113 cells, bands corresponding to 6H were observed 
in the supernatant fraction, and in some cases the periplasmic fraction, during immunoblot 
analysis (Fig. 3.1a). These data indicated that these proteins were separately expressed and 
targeted for extracellular secretion by E. coli. We next determined if these proteins could be 
simultaneously co-secreted in a single strain by the YebF pathway. Thus, we created plasmid 
pCEL4 which encodes all for YebF-cellulase fusions expressed polycistronically with different 
C-terminal epitope tags for discrete detection by immunoblot analysis. When this plasmid was 
transformed into wild-type BW25113 cells, bands corresponding to each epitope tag appeared in 
the supernatant fraction. Bands corresponding to YebF-Cel5B and YebF-Cel6A were also 
observed in the periplasm, though they are not as strong as the same bands observed in the 
supernatant (Fig. 3.1b), indicating that these proteins are efficiently translocated across the outer 
membrane. 
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Figure 3.1 Extracellular secretion of cellulases fused to YebF. Western blot analysis of 
periplasmic (per) and supernatant (sup) fractions of wild-type cells expressing YebF-cellulase 
fusions (a) individually or (b) simultaneously. Individually expressed cellulase fusions were 
detected using anti-6H antibody.  Simultaneously expressed YebF-cellulase fusions were detected 
using (from left to right) anti-cmyc, anti-FLAG, anti-6H, and anti-HA antibodies
!
! The experiments thus far suggest that our chosen four cellulases can be simultaneously 
synthesized and translocated to the extracellular medium by a single E. coli strain. We next asked 
the question whether expressing these proteins conferred upon these cells the ability to consume 
cellulose as a sole carbon source. Wild-type strains expressing each cellulase individually, or all 
per sup per supper supper sup
b
a
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Cel3A Cel5B Cel6A Cel9A
sup per sup per sup per sup
Cel3A Cel5B Cel6A Cel9A
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four cellulases in a single strain, were inoculated in M9 minimal medium containing 0.2% 
glucose or 1% carboxymethyl cellulose (CMC) or 0.34% cellobiose as a sole carbon source. As 
expected, all cells grew in the presence of glucose. Only cells carrying YebF-Cel3A were able to 
grow on cellobiose, whereas cells not expressing Cel3A exhibited no measurable growth (Table 
3.1.1). These data are consistent with the prediction that Cel3A has beta-glucosidase activity 
based on sequence similarity to known β-glucosidases. In the presence of CMC, no cellulase 
alone was enough to confer growth, but all four enzymes expressed together yielded observable 
growth (Table 3.1.1).
! Having observed that all four cellulases together conferred growth on CMC, we next 
asked whether all four are required to yield growth. To test which of the four enzymes were 
required for growth on CMC, cells individually expressing each YebF-cellulase fusion were co-
inoculated in liquid cultures. Among these cultures, a strain expressing a particular cellulase was 
not inoculated to determine that cellulase was required for growth. Cultures lacking cells 
expressing YebF-Cel6A and/or YebF-Cel9A were able to grow, whereas cultures lacking cells 
expressing YebF-Cel3A or YebF-Cel5B were not able to grow (Table 3.1.2). To test whether cells 
simultaneously expressing YebF-Cel5B and YebF-Cel3A are also able to utilize CMC, we 
constructed plasmid pCEL2, which encodes YebF-Cel5B and YebF-CEl3A bicistronically. Wild-
type cells harboring this plasmid were able to grow on CMC (Table 3.2.2). These data indicate 
that growth on CMC minimally requires beta-glucosidase activity and endoglucanase activity 
provided by Cel3A and Cel5B, respectively. No growth was observed in cells carrying pCEL4 in 
M9 minimial medium containing 1% AFEX-treated Avicel or 1% AFEX-treated corn stover (data 
not shown).
29
Empty Cel3A Cel5B Cel6A Cel9A CEL4
Glucose + + + + + +
Cellobiose - + - - - +
CMC - - - - - +
Table 3.1.1 Cell growth on glucose, cellobiose, or CMC as sole carbon sources. YebF-
cellulase fusions (Cel3A, Cel5B, Cel6A and Cel9A) or all four cellulase fusions together (CEL4) 
were inoculated in M9 minimal medium containing 0.2% glucose, 0.34% cellobiose, or 1% 
CMC. (+) and (-) indicate growth or no growth as measured by culture turbidity after 48 hours.
CEL4 CEL4 
(-Cel3A)
CEL4 
(-Cel5B)
CEL4 
(-Cel6A)
CEL4 
(-Cel9A)
CEL4
(-Cel6A, 
-Cel9A)
CEL2
CMC + - - + + + +
Table 3.1.2 Cell growth on CMC as a sole carbon source. All four YebF-cellulase fusions 
(CEL4) or missing one cellulase fusion (-Cel3A, -Cel5B, -Cel6A, or -Cel9A) were co-inoculated 
in M9 minimal medium containing 1% CMC. (+) and (-) indicate growth or no growth as 
measured by culture turbidity after 48 hours.
! Thus, far we have engineered normally non-cellulolytic E. coli cells with the ability to 
consume CMC as a sole carbon source by implementing the YebF secretion system for 
extracellular targeting of recombinant C. japonicus cellulases. The next step in the construction 
of a CBP platform is the conversion of the sugars obtained from cellulose hydrolysis to target 
chemical products. To advance to this step we chose to combine our engineered YebF-cellulases 
secretion system with a previously developed 1,2-propanediol pathway engineered for 
overexpression in E. coli (Altaras and Cameron, 1999). This pathway converts DHAP to 1,2-
proanediol in three transformations mediated by the biosynthetic enzymes methyglyoxyl 
synthase (mgsA), 2,5-diketo-D-gluconic acid reductase (DkgA) and glycerol dehydrogenase 
(GldA) (all from E. coli) (Altaras and Cameron, 2000). These enzymes were cloned tri-
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cistronically in expression vector pBAD18 to create plasmid p12PD and co-transformed with 
plasmid pCEL2 into wt W3110 cells. HPLC analysis revealed that these cultures produced 1,2-
propanediol up to a concentration of 0.3 g/L. Cells lacking either plasmid p12PD and pCEL2 
produced no measurable 1,2-PD, indicating that 1,2-PD production was dependent on both 
cellulolytic activity and overexpression of the 1,2-PD pathway. 
3.2 A universal approach for engineering extracellular pathways
! As a result of developing a CBP platform, we engineered cells capable of converting 
CMC to 1,2-PD by genetically amending E. coli cells with cellulase secretion activity and 1,2-
PD overexpression. However, these cells showed approximately at 2% yield of 1,2-PD from 
CMC, while previous studies have shown that the same cells showed approximately an 8% yield 
of 1,2-PD from glucose (Altaras and Cameron, 2000). Thus, we chose to engineer the YebF 
pathway for enhanced secretion efficiency in part to increase downstream production yields in 
CBP platforms. However, we lacked a high-throughput screening platform to engineer the YebF 
secretion pathway. In fact, the general studying and engineering of extracellular secretion 
pathways has been limited by the lack of a universally available phenotype for screening large 
libraries to identify rare genetic conditions that affect secretion activity. Therefore, a high-
throughput screening platform would be useful to better understand and engineer not just the 
YebF secretion pathway, but also other bacterial secretion systems used for secreting 
heterologous proteins, such as OsmY, OmpA, OmpF, and T2SS and T3SS.
! To address this limitation, we developed a readily identifiable secretion phenotype that is 
compatible with automated high-throughput screening of large genetic libraries, and is 
universally amenable to study and engineer virtually any extracellular secretion system in 
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bacteria. We screened for a fluorescent phenotype created by the exogenous reagent FLASH-
EDT2, which binds with high specificity to a tetracysteine motif CCXXCC (Griffin et al., 1998). 
The normally non-fluorescent FLASH-EDT2 becomes strongly fluorescent when bound to its 
ligand. Importantly, FLASH-EDT2 is not easily permeable to bacterial membranes (Ignatova and 
Gierasch, 2004), and could thus be added in situ to detect extracellular protein accumulation 
levels. We fused the C-terminus of YebF with peptide FLNCCPGCCMEP (labeled here as FT) 
that had previously been FACS-optimized for affinity and fluorescence, and followed by a 6H 
affinity tag (Fig. 3.2.1a) (Martin et al., 2005). Wild-type cells expressing the YebF-FT fusion 
protein generated a measurable fluorescent signal (Fig. 3.2.1b), and immunoblot analysis 
revealed a band corresponding to 6H in the supernatant (Fig. 3.2.1c). Interestingly, the signal was 
slightly enhanced in the absence of dsbA, presumably because the cysteine residues in the 
periplasmic compartment were maintained in a reduced state (Fig. 3.2.1b). As controls, YebF-FT 
lacking the Sec-dependent signal sequence (ΔssYebF-FT) or the FT epitope tag (YebF) generated 
no detectable signal (Fig. 3.2.1b), and no extracellular secretion was detected by immunoblot 
analysis (Fig. 3.2.1c). To test if YebF targeted for expression by the TAT-pathway could be 
secreted to the extracellular environment, the predicted Sec-dependent signal sequence was 
replaced with the leader sequence from native TAT substrate TorA (ssTorA- ΔssYebF). FlAsH 
and immunoblot analysis revealed that YebF-FT is not secreted to the extracellular medium when 
targeted for the Tat pathway, despite high level expression in the periplasmic compartment (Fig. 
3.2.1b and c). These data indicate that YebF translocation to the culture medium is dependent on 
its mode of inner membrane secretion. 
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Figure 3.2.1 A high-throughput screening platform for extracellular secretion of proteins. 
(a) Schematic of YebF fused to tetracysteine epitope (FT) binding to FLASH-EDT2 creating a 
fluorescent complex. (b) Relative fluorescence measurements of wild-type and ∆dsbA cells 
expressing full-length YebF-FT and derivatives lacking the signal peptide (∆sp), lacking the FT 
(∆FT), or with the signal peptide replaced with that of TorA (spTorA). (c) Western blot analysis 
of per and sup fractions of wild-type cells expressing YebF-FT and ∆sp and spTorA derivatives.  
Detection of each was performed by using an anti-6H antibody.
! The only genetic modification made for implementation of our FlAsH-based screen is the 
addition of a small epitope tag (18 amino acids) to the exoprotein of interest, in this case YebF, 
for specific interaction with the FlAsH-EDT2 reagent. Thus, we reasoned that this FlASH-based 
screening platform we developed initially for YebF could be transferred to other extracellular 
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secretion systems. To test this idea, we fused the C-terminal FT to other E. coli proteins that were 
previously observed to be released into the culture medium, OmpA (Xia et al., 2008), OmpF (Xia 
et al., 2008), and OsmY (Xia et al., 2008). Immediately following induction of these protein 
chimeras, the supernatant was isolated from the whole cell fraction to avoid labeling OmpA/F 
proteins that were retained within the outer membrane. FlAsH analysis of this cell-free 
supernatant resulted in measurable fluorescent signal for YebF-FT and OsmY-FT, and the YebF-
FT signal was approximately twice as intense as that of OsmY-FT (Fig. 3.2.2a).  No signal was 
observed from OmpA-FT and OmpF-FT (Fig. 3.2.2a). Immunoblot analysis corroborated the 
FlAsH-based observation that YebF-FT was secreted at significantly higher levels than OsmY-
FT, and also that OmpA-FT, and OmpF-FT were not detectable in the supernatant (Fig. 3.2.2b). 
Therefore we concluded that OmpA-FT and OmpF-FT were not efficiently secreted under these 
conditions, possibly because they remain associated with the outer membrane. Collectively, these 
data indicate that the FlAsH-based assay for extracellular secretion is a versatile procedure that is 
amenable to not just one secretion system. 
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Figure 3.2.2 YebF is secreted at significantly higher levels than OmpA, OmpF, and OsmY. 
(a)  FlAsH-analysis of C-terminal FT fusions in the cell-free supernatant. (b) Immunoblot 
analysis of each protein in the supernatant fraction. Detection of each was performed by using an 
anti-6H antibody. 
! Next, we tested if the FlAsH assay for protein secretion is compatible with T2SS. The 
T2SS encoded by the out gene cluster of Dickeya dadantii (formerly known as Erwinia 
chrsyanthemi) had previously been cloned in E. coli (He et al., 1991), enabling these cells to 
selectively secrete heterologous proteins, among them pectate lyase PelB. We fused the FT to the 
C-terminus of PelB and transformed this construct in wild-type MC4100 cells encoding the out 
gene cluster (out+). FlAsH analysis revealed a strong fluorescent signal in these cells over the 
same cells not carrying the out gene cluster (out-) (Fig. 3.2.3). Next, we removed genes encoding 
proteins essential for T2SS, outC and outD (∆outCD) (Lindeberg et al., 1996) and observed no 
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secretion of PelB-FT, as expected (Fig. 3.2.3). Finally, we complemented the outCD genes with 
functional copies from Dickeya dadantii (Dd-OutC, Dd-OutCD) or closely related species 
Pectobacterium carotovorum (Pc-OutC, Pc-OutCD), on a separate plasmid. Only Dd-OutC and 
Dd-OutCD from D. dadantii were able to restore secretion of PelB-FT in ∆outC and ∆outCD 
cells, respectively. These data are consistent with the previous observation that outC and outD 
from D. dadantii cannot be complemented by outC and outD from P. caratovorum, whereas the 
other genes in the D. dadantii out cluster can be complemented by their P. caratovorum 
counterparts (Lindeberg et al., 1996). Taken together, these data suggest that outCD are 
‘gatekeepers’ to species specificity of the T2SS. Importantly, the FlAsH assay developed here 
can be used in a high-throughput screen to target P. carotovorum outCD for laboratory evolution 
with the goal of overcoming the species specificity barrier of T2SS.
Figure 3.2.3 FlAsH analysis reveals species specificity among T2SS OutCD proteins. Wild-
type E. coli cells were co-transformed with a plasmid encoding the out cluster from D. dadantii 
(out+) and a plasmid expressing the PelB-FT construct. Genes outC (∆outC) or outC and outD 
together (∆outCD) were removed, and functional copies from D. dadantii (Dd-OutC and Dd-
OutCD) or from P. carotovorum (Pc_OutC and Pc_OutCD) were complemented in trans. These 
data confirm previously published results on outCD complementation (Lindeberg et al., 1996).
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! Finally, we tested if the FlAsH assay is compatible with the T3SS. The T3SS Hrp from D. 
dadantii functions in E. coli to secrete Psuedomonas syringae Avr proteins into plant cells and 
into the culture supernatant (Ham et al., 1998). Thus, we fused AvrPto with a C-terminal FT 
epitope and transformed this construct in DH5alpha cells carrying the D. dadantii Hrp system. 
Evidence from FlAsH analysis indicates that AvrPto-FT is secreted into the culture medium by 
these cells (Fig. 3.2.4). As a control, the same cells were used to express PelB-FT instead of 
AvrPto-FT, and this protein was not secreted at high levels, having only approximately 20% 
fluorescence signal compared to AvrPto-FT (Fig. 3.2.4a). Likewise, AvrPto-FT was not 
efficiently secreted by cells expressing the D. dandantii T2SS, and not the T3SS, while PelB-FT 
was secreted at high levels by these cells (Fig. 3.2.4a). Finally, we tested if the endogenous E. 
coli T2SS was amenable to FlAsH analysis. Thus, we fused ChiA to the C-terminal FT and 
transformed this construct into MC4100 cells lacking H-NS and over expressing the gsp gene 
cluster. These cells secreted detectable amounts of ChiA-FT, and were not able to secrete the 
AvrPto-FT protein (Fig. 3.2.4b). Interestingly, PelB-FT, which is a protein secreted by D. 
dadantii T2SS, was not secreted by the E. coli T2SS. These data indicate a stringent species 
specificity among gram-negative T2SS, which is consistent with previous observations 
(Lindeberg et al., 1996).
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Figure 3.2.4 FlAsH analysis to measure secretion of T2SS and T3SS functioning in E. coli. 
MC4100 wt  cells were transformed with D. dadantii T3SS and T2SS expression plasmids, and 
MC4100 ∆hns cells were transformed with E. coli T2SS expression plasmid. The secretion of 
AvrPto-FT, ChiA-FT, and PelB-FT in these strains was determined by FlAsH analysis. 
3.3 Isolation of genetic mutations with enhanced YebF secretion efficiency. 
! Among the single-domain proteins studied so far, YebF yielded a comparatively robust 
secretion signal in FlAsH and immunoblot analysis, and was successful in secreting four 
recombinant cellulases. Therefore, we targeted YebF for screening a genome-wide Tn5 
transposon insertion library to isolate genetic mutants that confer enhanced secretion activity. 
This transposon library was generated in BW21153 ∆dsbA cells carrying the YebF-FT expression 
plasmid (Donath et al., 2011). The resulting mutants were screened for fluorescence activity in 
the presence of FLASH-EDT2 and a B-score was assigned to each mutant as described 
previously (Malo et al., 2006). This analysis produced eight ‘hits’ with statistically significant 
increase in fluorescent signal (Fig. 3.3a).  A ‘clean’ deletion of these genes in BW25113 (now 
dsbA positive) cells also resulted in improved the fluorescent signal over the parent strain (Fig. 
3.3b).  Finally, when functional copies of each gene was complement in trans, the fluorescence 
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activity returned to wild-type levels, indicating that each deletion was responsible for enhance 
secretion and that the phenotype is not due to polar effects (Fig. 3.3b).
Figure 3.3  Isolation of genetic mutants with enhanced YebF transport. (A) B score analysis 
of ‘hits’ from high-throughput screening of transposon insertion library.  (B) Fluorescent signals 
of cells with ‘clean’ deletions of genes identified in high-throughput screening (dark columns).  
Genes were complemented in trans (light columns).
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3.4 Characterization of outer membrane permeability of isolated mutants.
! The genetic mutations isolated here enhanced the extracellular accumulation of YebF. 
However, it is not clear if increased accumulation levels are the result of a compromise in 
membrane integrity in these mutants resulting in cellular proteins passively ‘leaking’ into the 
extracellular space, and not active secretion. To test this notion, we performed a thorough 
examination of membrane integrity by performing a series of previously established protocols 
that probe membrane integrity in E. coli mutants (McBroom et al., 2006). These protocols 
include measuring leakage of cellular proteins RNase I, MBP, and DsbA, and also sensitivity to 
the detergent deoxycholate (McBroom et al., 2006). The apparent hyper-secreting mutation 
ΔompR exhibited a measurable amount of RNAse I, MBP, and DsbA leakage, as well as 
increased detergent sensitivity (Table 3.4). Importantly, these results are consistent with previous 
observations that E. coli ∆ompR cells have a compromised outer membrane and leak cellular 
proteins to the extracellular space (McBroom et al., 2006). Also, cells lacking envZ gave a 
similar phenotype in these analyses (Table 3.4). Based on these results, we concluded that 
increased secretion of YebF by cells lacking envZ or ompR may be at least partly attributed to 
increased outer membrane instability resulting in passive diffusion of cellular proteins into the 
extracellular space. For these reasons, cells lacking envZ or ompR were not included in further 
analyses.  
40
Table 3.4 Characterization of outer membrane integrity and permeability.
wt ΔentC ΔentE ΔenvZ ΔmzrA ΔnlpD ΔompR ΔtnaA ΔyihF
RNAseI 
leakagea - - - + - - ++ - -
Detergent 
sensitivityb - + - ++ - + ++ - -
MBP leakagec - - - ++ + - + - -
DsbA leakagec - - - ++ + - + - -
a-.no clearing; +, moderate clearing; ++, significant clearing. 
b-, resistant; +, mildly sensitive; ++, sensitive. 
c-, none detectable; +, low amount; ++, high amount.
!
3.5 Enhanced secretion of YebF-cellulase fusions
! The mutations isolated in this study have significantly increased the extracellular 
accumulation of YebF. We were interested to know whether these mutations had the same effect 
on YebF-protein fusions, particularly the cellulase proteins that we used to develop a CBP 
platform earlier in this study. Thus, we next determined whether these mutations could 
upregulate the secretion of YebF-cellulase fusions. The same plasmids encoding the YebF-
cellulase fusions (see Fig. 3.1) were transformed in wild-type and six mutant strains determined 
not to be leaky (see Table 3.4)  and secretion of the fusion proteins to the supernatant fraction 
was detected by immunoblot analysis using an anti-6H antibody (Fig. 3.5a). As expected, each of 
the six mutations showed an increase in unfused YebF secretion relative to the wt host. 
Remarkably, all six mutants were able to dramatically upregulate the secretion of YebF-Cel3A 
into the supernatant, and all mutants, with the exception of ∆entC increased secretion of YebF-
Cel5B (Fig. 3.5a) 
! If these mutants are more efficient at secreting YebF-Cel3A and YebF-Cel5B, the two 
enzymes required for growth on CMC (Fig. 3.1.2), then it stands to reason that these mutants 
have a faster growth rate in the presence of CMC when expressing these two proteins 
41
simultaneously. Thus, we tested if these mutants had an increase in specific growth in the 
presence of CMC when expressing pCEL2. A growth curve was generated of cells carrying 
pCEL4 in M9 minimal medium containing 1% CMC and specific growth rates were calculated 
(Fig. 3.5b). Up to a 1.5 fold increase in growth rate was observed in ∆tnaA cells. We also tested 
whether these mutations increased 1,2-PD when introduced in our previously engineered CBP E. 
coli cells (Fig. 3.1), though no increase in 1,2-PD was observed (data not shown). 
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Figure 3.5 Enhanced extracellular secretion of YebF and YebF-cellulase fusions.  (a) 
Extracellular secretion of YebF-cellulase fusions by hypersecretion mutations. Detection of YebF, 
YebF-Cel3A and YebF-Cel5B in cell-free supernatant fractions was performed using an anti-6H 
antibody. (b) Specific growth rate of hypersecreting mutants carrying plasmid pCEL2 in the 
presence of 0.34% cellobiose.
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3.6 Discussion
! This study and others have demonstrated that recombinant enzymes synthesized in E. coli 
can be targeted for export out of cells when fused C-terminally to the YebF protein (Zhang et al., 
2006; Fisher et al., 2011). However, until now, the unanswered question remained whether the 
YebF pathway could be exploited to simultaneously co-secrete different heterologous proteins. 
This feature would be particularly useful in CBP organisms where more than one different 
cellulase is necessary to achieve sufficient hydrolysis of lignocellulosic substrates (Liao et al., 
2011). Here, we show evidence that a single host can secrete at least four recombinant proteins 
when fused genetically to the YebF domain (Fig 3.1b). Furthermore, we discovered that of these 
four enzymes, only the predicted beta-glucosidase, encoded by Cel3A, and the endoglucanase, 
encoded by Cel5B, were required for the consumption of CMC as a sole carbon source. This 
observation was a critical step in developing a CBP platform that could convert the CMC to 
target chemical products. We chose the production of 1,2-propanediol because the metabolic 
pathway for 1,2-propanediol had previously been established and optimized in E. coli (Altaras 
and Cameron, 1999; 2000). Collectively, we demonstrated the direct conversion of CMC to 
measurable amounts of 1,2-propanediol. Our CBP system may be useful for engineering the 
CBP-mediated conversion of more complex cellulosic and lignocellulosic feedstocks, like 
pretreated switchgrass or corn stover. 
! The secretion of YebF into the periplasmic compartment occurs natively via the Sec 
pathway, and then YebF is translocated across the outermembrane by OmpF/C (Prehna et al., 
2012) An interesting observation from our studies is that YebF targeted for expression via the Tat 
pathway is efficiently transported into the periplasm, but cannot be transported across the outer 
membrane. The YebF protein is likely in a folded state when it reaches the periplasm because the 
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intrinsic quality control mechanism of Tat transport dictates that secretory porteins are fully 
folded in the cytoplasmic compartment prior to export (DeLisa et al., 2003). Thus, one possible 
explanation is that YebF-mediated extracellular secretion requires an unfolded or semi-unfolded 
protein confirmation that may be required for threading through the lumen of OmpF (Prehna et 
al., 2012). This explanation is compatible with the ability of the YebF system to secrete different 
large recombinant proteins (Zhang et al., 2006; Fisher et al., 2011).
! An important outcome of our studies is the development of a versatile assay for studying 
secretion systems by labeling secreted proteins with the FlAsH-EDT2 reagent. The reagent 
FlAsH-EDT2 was first developed to label intracellular proteins in eukaryotic cells (Griffin et al., 
1998), but few studies have successfully demonstrated labeling intracellular proteins in bacteria, 
possibly due to the impermeability of the membrane to the FlAsH-EDT2 compound (Ignatova 
and Gierasch, 2004). While this may be a limitation for labeling proteins with FlAsH-EDT2 in 
certain applications, we relied on this impermeability to rapidly label secreted proteins in the 
extracellular environment without the need to first isolate the cell-free supernatant. This feature 
is particularly useful for automated screening of large genetic libraries. Thus, we were able to 
screen a genome-wide transposon insertion library, and we identified eight different genetic 
mutations that resulted in enhanced production of YebF in the culture medium. Remarkably, the 
enhanced accumulation of YebF in some of these mutants extended to YebF-protein fusions. This 
is an important observation because it represents a critical step in engineering superior 
expression hosts capable of secreting recombinant proteins to the culture medium at high titers.  
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3.7 Materials and methods
3.7.1 Bacterial strains, plasmids, and growth conditions
! E. coli strain BW25113 (lacIq rrnBT14 ∆lacZWJ16 hsdR514 ∆araBADAH33 ∆rhaBADLD78) 
and single-gene knockout mutants of BW25113 from the Keio collection (Baba et al., 2006) 
were used for all experiments unless otherwise noted. Strains were routinely grown aerobically at 
37°C in Luria-Bertani (LB) medium, and antibiotics were supplemented at the following 
concentrations: ampicllin (Amp, 100 μg/ml); kanamycin (Kan, 50 μg/ml); chloramphenicol (Cm, 
100 μg/ml). Protein synthesis was induced when the cells reached an absorbance at 600 nm 
(Abs600) of ~0.5 by adding 0.2% arabinose and/or 1 mM isopropyl-β-d-thiogalactopyranoside 
(IPTG) to the media. E. coli strains were grown on M9 minimal medium (ref) supplemented with 
supplemented with MgSO4 (1 mM) and CaCl2 (0.1 mM). Glucose (0.2% [wt/vol]), cellobiose 
(0.34% [wt/vol]), carboxymethylcellulose (CMC) (1% [wt/vol]), and Avicel (1% [wt/vol]) were 
used as sole carbon and energy sources for cells grown in minimal medium.
3.7.2 Plasmid construction
! Plasmid pTrc-YebF was created by insertion of DNA encoding yebF between SacI and 
XbaI of pTrc99a. Plasmid pCEL4 was synthesized (GeneArt) for codon-optimized polycistronic 
expression of cel6A, cel9A, cel5B, and cel3B. Plasmids pCel45A and pCel5D were synthesized 
(GeneArt) for codon-optimized expression of Cel45A and Cel5D, respectively. Each 
commercially synthesized cellulase was PCR amplified and inserted in between XbaI and 
HindIII of pTrc-YebF to create pTRC-YebF-Cel3A, pTRC-YebF-Cel5B, pTRC-YebF-Cel5D, 
pTRC-YebF-Cel6A, pTRC-YebF-Cel9A and pTRC-YebF-Cel45A, respectively. A reverse primer 
encoding 6X-His (6H) was used during PCR amplification to create a C-terminal 6H tag on each 
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plasmid. To create plasmid pYebF-Cel4, YebF-Cel6A, YebF-Cel9A, YebF-Cel5B, and YebF-
Cel3B were PCR amplified with reverse primers containing 6H, HA, Flag, and Cmyc tags 
respectively. Then, each cellulase gene on pCEL4 was replaced with its respective YebF-
cellulase fusion. To create pTrc-YebF-FT and pTrc-∆spYebF-FT, YebF and ∆spYebF were PCR 
amplified using a reverse primer containing the FT and 6H sequence and inserted into SacI and 
XbaI of pTrc99a. Plasmids pTrc-spTorA-∆spYebF-FT was created by inserting spTorA between 
NcoI and SacI of pTrc-∆spYebF-FT. Plasmids expressing entC, entE, envZ, mzrA, nlpD, ompR. 
tnaA, and yihH were constructed by inserting DNA encoding a Shine-Dalgarno sequence 
followed by these genes in between SacI and XbaI of pBAD33. All primers were synthesized by 
Integrated DNA Technologies (IDT).
3.7.3 Protein analysis
! Cells expressing recombinant proteins were harvested 4-6 h after induction at 30˚C. Cell-
free supernatant fractions were prepared by centrifugation at 5,000 g for 10 min, and the proteins 
were precipitated overnight with 1% TCA at 4˚C. After centrifugation at 13,000 RPM for 30 min, 
the pellet was washed once with ice-cold acetone and dissolved in 1M Tris-HCl. pH 8.0 and an 
equal volume of electrophoresis loading buffer. The periplasm was separated from the cytoplasm 
using the osmotic shock method (Kim et al., 2005). All proteins samples were loaded in equal 
amounts for separation on an SDS-PAGE gel and then transferred to a nitrocellulose membrane 
for immunoblotting. The following primary antibodies were used: mouse anti-6H (1:3,000; 
Qiagen); mouse anti-FLAG (1:1,000; Stratagene); rabbit anti-C-myc (1:1,000; Sigma); rabbit 
anti-HA (1:1000; Sigma); rabbit anti-DsbA (1:20,000; gifted); mouse anti-MBP (1:2,000, New 
England Biolabs).
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3.7.4 Transposon insertion library generation
! A genome-wide transposon Tn5 insertion library was generated in strain EC100 using the 
EZ-Tn5™ <R6Kγori/KAN-2>Tnp Transposome Kit according to the manufacturer’s instructions 
(Epicentre, Madison, WI). Following electroporation of the transposome into the recipient strain, 
the outgrowth was plated on LB agar medium supplemented with 50 µg/ml kanamycin. After 
overnight grown at 37°C, the plates were flooded with LB medium and any visible colonies 
scraped off with a cell spreader.  The cell suspension was supplemented with glycerol to a final 
concentration of 30% glycerol and stored at -80°C. The Tn5 library frozen stock provided the 
donor strains for a P1-phage library of secretion mutants. Overnight cultures inoculated with the 
Tn5 library frozen stock were grown in 5 ml of LB medium supplemented with 50 µg/ml 
kanamycin. The overnight cultures were subcultured 1:25 in 50 ml of LB medium supplemented 
with 5 mM CaCl2, 0.2 % glucose, and 50 µg/ml kanamycin. Following 1 hour of incubation at 
37°C with shaking, 0.625 ml of P1-phage stock was added to the flask. The growth of the culture 
was monitored by OD600. After several hours, a precipitous drop in OD600 was typically 
observed. The cultures were harvested 1 hour after the drop in OD600. Twenty-five ml of culture 
was added to two 50 ml conical centrifuge tubes along with 0.635 ml of chloroform. Each tube 
was vortexed briefly and centrifuged at 10,000 x g for 5 minutes. The resulting P1 lysates from 
the supernatant were stored at 4°C and used to produce YebF secretion libraries. Thirty milliliters 
of overnight culture (30 ml) of E. coli BW25113 ΔdsbA harboring pTrc-YebF-FT was 
centrifuged at 6,000 xg for 5 min. The pellet was resuspended in 30 mL of LB medium 
supplemented with 100 mM MgSO4 and 5 mM CaCl2 then incubated at 30°C with 3 ml of P1 
phage stock. After 30 minutes, 6 ml of 1 M sodium citrate was added to stop the reaction. The 
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cells were again pelleted at 6,000 x g for 5 minutes and resuspended in 10 mL of LB 
supplemented with 100 mM sodium citrate. The transduced cells were plated onto Omniwell 
plates (Nunc) containing LB agar medium supplemented with 50 µg/ml kanamycin and 100 µg/
ml ampicillin.
3.7.5 FlAsH Screening of YebF secretion mutants
! Individual clones were robotically picked into wells of 96-well bar-coded microtiter 
plates containing 100 µl of LB medium supplemented with 50 µg/ml kanamycin and 100 µg/ml 
ampicillin. The picked clones were incubated with shaking overnight at 30°C and high humidity. 
The plates containing overnight cultures were loaded onto a Tecan Freedom EVO 200 liquid 
handling robot where all remaining processing was performed. The overnight cultures were 
subcultured (1:10) into clear-bottom black microtiter plates with 180 µl of LB medium in each 
well supplemented with 0.5 mM IPTG, 50 µg/ml kanamycin, and 100 µg/ml ampicillin. The 
remaining overnight culture was supplemented with glycerol to a final concentration of 30% 
glycerol and stored at -80°C.  After 24 hours incubation with shaking at 30°C and high humidity, 
the subcultured plates were assayed for Flash-tagged YebF secretion. Each culture was assayed 
for cell growth by measuring OD600, then 20 µl of concentrated assay cocktail containing 10 
µM FlAsH-EDT (Invitrogen) and 500 µM 2,3 dimercaptopropanol was added to each well. The 
plates incubated with shaking for an additional hour before reading the culture fluorescence 485 
nm/528 nm.
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3.7.6 Characterization of outer membrane permeability
! Assays for detergent sensitivity and RNase I, MBP, and DsbA leakage were performed 
essentially as described before (McBroom et al., 2006).  
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CHAPTER 4
AN ENGINEERED GENETIC SELECTION FOR EXTRACELLULAR SECRETION
4.0 Introduction
! The approach for engineering extracellular secretion pathways developed in Chapter 3 
relies on labeling exoproteins with an exogenous reagent FlAsH-EDT2. The nature of this assay 
means that genetic or other libraries must be screened by a mechanical system, such as with a 96- 
or 384-well plate reader. Even with automated systems, this can limit the size of the libraries 
screened. Therefore, this approach may not be fruitful for some applications that require large 
library sizes or multiple combinatorial libraries, such as the laboratory evolution of proteins 
(Stemmer, 1994; You and Arnold, 1996). An alternative approach where extracellular protein 
secretion is linked to cell viability would streamline the isolation of rare genetic events that affect 
secretion activity by eliminating the need to screen individual clones. For example, a genetic 
selection where the non-secretory phenotype is lethal would be more suitable for laboratory 
evolution of protein machinery and screening large or multiple genetic libraries.
! Beta-lactam antibiotics are among the most frequently used antibiotics, and the activity of 
beta-lactamase (Bla) enzymes has been used extensively in engineered genetic selections for 
studying and engineering protein secretion, solubility, and stability (Fisher et al., 2006; Waraho 
and DeLisa, 2009; Mansell et al., 2010). One method for overcoming beta-lactamase-mediated 
drug resistance is by a 165-amino acid beta-lactamase inhibitor protein (BLIP) that is 
synthesized by Streptomyces clavuligerus (Paradkar et al., 1996). The BLIP protein is a potent 
inhibitor of class A beta-lactamase, including TEM1 (Ki = 0.1 to 0.6 nm) (Zhang and Palzkill, 
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2003). This activity of BLIP has previously been harnessed in a dual genetic selection to screen 
error-prone libraries of LuxR for altered signaling specificity in quorum sensing (Collins et al., 
2006). Here, we describe the use of BLIP / Bla in an engineered genetic selection for studying 
and engineering extracellular secretion pathways. This strategy was successfully implemented 
for studying the secretory mechanisms of the YebF pathway and also the type II secretion 
system. 
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4.1 An engineered genetic selection for extracellular secretion of proteins
Figure 4.1.1 An engineered genetic selection for extracellular secretion of proteins. The 
exoprotein of interest, in this case YebF, is fused N-terminally to BLIP and TEM-1 Bla is co-
expressed in these cells. Under conditions that hinder the translocation of YebF-BLIP across the 
outer membrane, the YebF-BLIP protein is retained in the periplasm where it inhibits the activity 
of Bla, and the result is that cells are less viable in the presence of beta-lactam antibiotics (left 
panel). By contrast, under conditions of secretion, the YebF-BLIP protein is localized to the 
extracellular space and Bla remains active, and the result is that cells are more resistant to beta-
lactam antibiotics (right panel). 
! To create a genetic selection for extracellular secretion, we created a host-vector system 
where the non-secretory phenotype is lethal. We relied on the beta-lactamase inhibitor protein 
(BLIP), which binds to and inhibits β-lactamase (Bla) with a Ki of 0.1 to 0.6 nM (Zhang and 
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Palzkill, 2003). We genetically fused BLIP to the C-terminus of YebF and hypothesized that cells 
would become less viable under conditions of non-secretion in the presence of beta-lactam 
antibiotics, such as carbenicillin (Carb) (Fig. 4.1.1). A leaderless YebF domain was inserted 
between the Sec-dependent signal sequence of BLIP (ssBLIP) and mature protein of BLIP 
(dssBLIP) to create a YebF-BLIP fusion with the native BLIP signal sequence. This genetic 
fusion was ligated into expression vector pTrc99a (Amann et al., 1988), whereby Bla is 
expressed constitutively from the vector backbone, creating plasmid pTRC-YebF-BLIP. As 
controls, we made derivatives of pTRC-YebF-BLIP that express full-length BLIP without the 
YebF domain (pTRC-BLIP), and also YebF-BLIP without an inner membrane secretion signal 
(pTRC-∆ss-YebF-BLIP). These plasmids were tranformed in wt BW25113 cells and overnight 
cultures of were diluted 10-1 to 10-8 and each dilution was spotted in equal volumes on LB agar 
plates containing a range of Carb concentrations from 0 (-Carb) to 100 µg/mLµg/mL (+Carb) 
(Fig. 4.1.2a). In this spot plate analysis, we observed that the expression BLIP protein without 
the YebF fusion was significantly attenuated for growth compared to the YebF-BLIP fusion (Fig. 
4.1.2a).  As expected, cytoplasmic expression of the YebF-BLIP construct encoded by ∆ssYebF-
BLIP showed no observable attenuation of growth compared to empty vector cells. To test if the 
difference in cell viability between YebF-BLIP and BLIP was due to the localization of the BLIP 
protein, we performed an immunoblot analysis of cell-free supernatant fractions from cells 
expressing each protein. In cells expresing YebF-BLIP, a strong band corresponding YebF-BLIP, 
whereas only a faint band corresponding to BLIP appeared in cells expressing the BLIP construct 
(Fig. 4.1.2b) Finally, no band was detected in cells expressing ∆ss-YebF-BLIP. These results 
indicate that efficient secretion of BLIP requires the presence of the N-terminal signal sequence 
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and the YebF secretion domain. It also supports the notion that cell viability in spot plating 
analysis is linked to the localization of the BLIP protein.
! Encouraged by these results, we tested if we could select for cells expressing the YebF-
BLIP fusion reporter from a mixed population of cells expressing either YebF-BLIP or BLIP 
proteins. Overnight cultures of the YebF-BLIP and BLIP hosts were mixed in equal amounts and 
plated to single colony resolution on 100 µg/mL Carb and 0 µg/mL Carb. Plasmids from ten 
randomly selected colonies were isolated and treated with EcoRI and HindIII to release either the 
BLIP or YebF-BLIP inserts, with predicted sizes of 672 bp and 948 bp, respectively. These 
studies revealed that 10/10 selected colonies from the Carb (100 µg/mL) plates had plasmids 
with the YebF-BLIP insert (data not shown). Only 3/10 colonies selected in the absence of Carb 
had the YebF-BLIP insert (data not shown). These data indicate that we can effectively select 
against cells not efficiently secreting the BLIP protein.
! Finally, we were interested to know if this BLIP / Bla genetic selection was limited to just 
the YebF pathway, or if it could be extended to other secretion systems. To test if we could 
generate a similar genetic selection for T2SS, we fused the T2SS-secreted protein PelB to the N-
terminus of BLIP followed by a 6H affinity tag and cloned this fragment into expression vector 
pTrc99a (Amann et al., 1988) for constitutive co-expression of Bla from the vector backbone. 
This plasmid was transformed in cells expressing the functional out cluster for Dickeya dadantii, 
and also the nonfunctional out cluster lacking the essential genes outC and outD. In cells 
encoding non-fuctional out clusters, functional copies of outC and outD from D. dadantii and P. 
carotovorum were provided on a separate plasmid. These cultures were diluted 10-1 and plated on 
LB agar containing 25 µg/mL Carb (Fig. 4.1.2). Under these conditions, only cells containing 
outCD genes from D. dadantii grew, where as cells expressing outCD from P. carotovorum did 
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not grow (Fig. 4.1.2c). This is consistent with our previous observation that PelB is secreted by 
D. dadantii outCD but not by P. carotovorum outCD (see Fig. 3.2.3), and this is also consistent 
with a previous study on this T2SS (Lindeberg et al., 1996). Taken together, these data provide 
compelling preliminary evidence that the BLIP / Bla selection can be used to study and engineer 
T2SS and YebF secretion pathways.
Figure 4.1.2 A BLIP / Bla genetic selection for engineering YebF and T2SS pathways (a) 
Wild-type cells harboring an empty vector (empty), a YebF-BLIP fusion lacking the Sec-
dependent signal sequence (∆ss-YebF-BLIP), full-length blip lacking the YebF secretion domain 
(BLIP), and a full-length YebF-BLIP fusion (YebF-BLIP) were diluted 1/10 and spotted in equal 
amounts on 100 µg/mL Carb (+ Carb) or no Carb (- Carb). (b) Immunoblot analysis of ∆ss-
YebF-BLIP, BLIP,  and YebF-BLIP proteins. Proteins were detected in the supernatant fraction 
using an anti-6H antibody. (c) Overnight cultures of MC4100 cells harboring PelB-BLIP and 
either the out gene cluster (out+) or the out gene cluster lack outCD (∆outCD) were diluted 1/10 
and spot plated on 25 µg/mL Carb (+Carb).
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4.2 Discussion 
! To our knowledge, this study provides the first evidence for a general genetic selection 
for extracellular protein secretion in bacteria. The versatility of this genetic selection is in part 
attributed to the BLIP protein, which is a small protein (167 aa) that can be fused to virtually any 
exoprotein of interest. In this manner, the BLIP / Bla genetic selection is not limited to just one 
extracellular secretory mechanism, but can be in principle be applied to any two-step 
extracellular secretion system in gram-negative bacteria.  This speculation is supported by our 
observation that the genetic selection was compatible with both the YebF secretion pathway and 
also the T2SS from D. dadantii functioning in E. coli. 
! We predict that this selection technology will be useful for reprogramming secretory 
pathways with enhanced efficiency and new activities. For instance, it should be possible to 
screen variants of YebF or other proteins in the YebF pathway, such OmpF/C or OmpX, to find 
mutations that enhance the secretion activity of YebF or YebF-protein fusions. Also, the T2SS is 
known to have a stringent species specificity whereby proteins from a closely related organism 
cannot be secreted by the secretion system of another organism (Lindeberg et al., 1996). This 
species specificity barrier is thought to be encoded by the outC and outD genes as they are the 
only genes in the D. dadantii out cluster that cannot be complemented by those from the closely 
related organism P. carotovorum (Lindeberg et al., 1996). Importantly, these results are 
consistent with our observation that cells functioning in our selection system are significantly 
less viable when expressing the Pc-OutCD instead of the Dd-OutCD. Thus, our system may be 
well-suited for laboratory evolution of the Pc-OutCD proteins to find variants with relaxed 
substrate specificity. 
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4.3 Materials and methods
4.3.1 Bacterial strains, plasmids, and growth conditions
! E. coli strain BW25113 (lacIq rrnBT14 ∆lacZWJ16 hsdR514 ∆araBADAH33 ∆rhaBADLD78)  
were used for all experiments unless otherwise noted. Strains were routinely grown aerobically at 
37°C in Luria-Bertani (LB) medium, and antibiotics were supplemented at the following 
concentrations: ampicllin (Amp, 100 μg/ml); kanamycin (Kan, 50 μg/ml); chloramphenicol (Cm, 
100 μg/ml); spectinomycin (Spec, 100 µg/mL). Protein synthesis was induced when the cells 
reached an absorbance at 600 nm (Abs600) of ~0.5 by adding 0.2% arabinose and/or 1 mM 
isopropyl-β-d-thiogalactopyranoside (IPTG) to the media.
4.7.2 Plasmid construction
! Plasmid pTRC-ssBLIP-YebF-BLIP was created by inserting the ssBLIP signal sequence 
in EcoRI SacI, leaderless YebF in SacI XbaI and leaderless BLIP with a C-terminal 6H affinity 
tag between XbaI and HindIII of pTrc99a. Plasmid pTRC-dssYebF-BLIP and pTRC-BLIP were 
created by removing the ssBLIP signal sequence and leaderless YebF by restriction digest, 
respectively. Plasmid pTRC-PelB-BLIP was created by inserting PelB between SacI and XbaI 
and leaderless BLIP with a C-terminal 6H between XbaI and HindIII. The sequence of all 
plasmids was confirmed by sequencing.
4.7.3 Protein analysis
! Cells expressing recombinant proteins were harvested 4-6 h after induction at 30˚C. Cell-
free supernatant fractions were prepared by centrifugation at 5,000 g for 10 min, and the proteins 
were precipitated overnight with 1% TCA at 4˚C. After centrifugation at 13,000 RPM for 30 min, 
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the pellet was washed once with ice-cold acetone and dissolved in 1M Tris-HCl. pH 8.0 and an 
equal volume of electrophoresis loading buffer. All proteins samples were loaded in equal 
amounts for separation on an SDS-PAGE gel and then transferred to a nitrocellulose membrane 
for immunoblotting. The following primary antibodies were used: HRP-conjugated mouse 
anti-6H (1:3,000; Qiagen).
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CHAPTER 5
ENVELOPE STRESS IS A TRIGGER FOR CRISPR RNA-MEDIATED DNA SILENCING IN 
ESCHERICHIA COLI2
! The ability to move proteins across the cytoplasmic membrane, and very often out of the 
cell completely, is a key aspect of the physiology and pathogenicity of gram-negative bacteria. 
Thus, the exploitation of cellular protein biosynthesis machinery and secretory mechanisms is 
not without consequences to the host. Protein overexpression can induce cell stress responses, 
particularly when these proteins misfold and are targeted for secretion pathways (Darwin, 2005). 
Because protein secretion is essential for cellular physiology, ‘jamming’ secretion pathways with 
misfolded proteins can induce envelope stress responses that can regulate genes for maintaining 
cell envelope homeostasis. For example, in E. coli the mislocalization of secreted proteins that 
disrupt the proton motive force along the inner membrane induces stress response pathway called 
the phage-shock response (Psp) (Darwin, 2005). This observation is supported by a related study 
that showed that saturation due to protein overexpression along the Tat pathway, which relies on 
the proton motive force for energy, can be relieved by the Psp protein PspA (DeLisa et al., 2004). 
Protein misfolding can also induce additional stress response pathways with different but 
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2Adapted with permission from: 
Perez-Rodriguez R.*, C.H. Haitjema*, Q. Huang, K. H. Nam, S. Bernardis, A. Ke, and M. P. DeLisa. 2011. 
Envelope stress is a trigger of CRISPR RNA-mediated DNA silencing in Escherichia coli. Mol Microbiol 79:584–
599. *These authors contributed equally to this work
Nam K.H., C.H. Haitjema, F. Ding, M.P. DeLisa, and A. Ke. 2012. Cas5d protein processes pre-crRNA and 
assembles into a Cascade-like interference complex in subtype I-C/Dvulg CRISPR-Cas system. Structure (in press)
overlapping functions. The Bae and Cpx two-component system response regulators have been 
known to respond to envelope stress caused by protein misfolding (MacRitchie et al., 2008). 
! In this chapter, I describe the Bae-mediated response to a misfolded protein targeted for 
secretion by the Tat pathway. Interestingly, part of this Bae-mediatesd response is the induction 
of the CRISPR Cas system, which functions to silence the plasmid DNA encoding the misfolded 
protein. It should be noted that much of the work presented in this chapter is by a co-author, 
Ritsdeliz Perez-Rodriguez. While I am also a co-first author of this work, my contribution to this 
project are in the latter parts of this chapter, particularly subsections 5.5 through 5.7. The other 
sections are included to provide context. Finally, section 5.8 is a separate but related study of 
mine on the CRISPR Cas Dvulg subtype, encoded by Bacillus halodurans, which was partially 
reconstituted in E. coli cells to reveal functional complementarity between these two systems.
5.0 Introduction!
! The use of small RNAs to regulate gene expression is ubiquitous in all living organisms 
(Waters and Storz, 2009). In one remarkable instance, bacteria and archaea acquire resistance to 
bacteriophages and conjugative plasmids by employing an RNA-mediated defense mechanism 
against these foreign invaders. In this process, short fragments (∼24–48 nucleotides) of the 
invading DNA are integrated in the genome as spacers between similarly sized clusters of 
regularly interspaced short palindromic repeats (CRISPR) loci (Bolotin et al., 2004; Makarova et 
al., 2006; Barrangou et al., 2007; Brouns et al., 2008; Sorek et al., 2008; Lillestøl et al., 2009). 
CRISPR loci have been identified in nearly all archaeal genomes and almost half of eubacterial 
genomes that have been sequenced to date (Sorek et al., 2008). They are often adjacent to an 
operon that encodes the CRISPR-associated (Cas) proteins (Fig. 5.1A), which are predicted 
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RNA binding proteins, endo- and exo-nucleases, helicases and polymerases (Haft et al., 2005; 
Makarova et al., 2006). Bacteria encoding CRISPR-Cas systems that have been exposed to a 
virus or conjugative plasmid integrate phage- or plasmid-derived spacer sequences into the 
leader-proximal end of their CRISPR loci (Barrangou et al., 2007). The appearance of acquired 
spacer DNA in the genomes of these bacteria correlates with viral or plasmid resistance in a 
process that is dependent upon several of the cas gene products (Barrangou et al., 2007; Brouns 
et al., 2008).
! A key feature of CRISPR-encoded immunity is an inhibitory ribonucleoprotein complex 
comprised of a subset of Cas proteins and a guide RNA. This complex is believed to be 
responsible for targeting foreign genetic elements through base pairing between the bound RNA 
guide and either the sense or antisense strands of the target (Brouns et al., 2008). The formation 
of the guide RNAs begins when the CRISPR repeat-spacer arrays are transcribed from the leader 
region, producing a CRISPR transcript called the pre-crRNA (Hale et al., 2008; Lillestøl et al., 
2009). The full-length pre-crRNAs are subsequently processed into small CRISPR RNA 
(crRNA) molecules that correspond to a spacer flanked by two partial repeats (Tang et al., 2002; 
Brouns et al., 2008; Hale et al., 2008). How the expression of CRISPR arrays and cas genes is 
regulated when the cell is threatened by foreign DNA is poorly understood, although in 
Escherichia coli it appears to involve H-NS repression, which silences transcription from the 
CRISPR-Cas promoters (Pul et al., 2010), unless relieved by the transcriptional activator LeuO 
(Westra et al., 2010).
! The production of crRNAs is carried out by distinct Cas proteins in different organisms. 
In Pyrococcus furiosus, Cas6 processes pre-crRNA to release individual invader-targeting RNAs 
and remains bound to the CRISPR repeat sequences at the 5" end of the cleavage product (Carte 
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et al., 2008). In E. coli, which lack Cas6, as many as five Cas proteins – CasABCDE – reportedly 
form a complex called CRISPR-associated complex for antiviral defence (Cascade) that 
processes CRISPR RNA (Brouns et al., 2008). Of these five enzymes, the catalytic activity of the 
CasE subunit is essential for pre-crRNA cleavage, which occurs within each repeat of the 
CRISPR RNA precursor (Brouns et al., 2008; Carte et al., 2008). Processed crRNAs encode the 
entire spacer unit flanked by the last eight bases of the repeat sequence at the 5" end and a less 
well-defined 3" sequence that ends in the next repeat region (Brouns et al., 2008; Carte et al., 
2008). As mature crRNAs are similar at their 5" but not their 3" ends implies that this region may 
serve as a conserved binding site for Cas effector subunits, as suggested previously (Kunin et al., 
2007; Carte et al., 2008). However, whether Cas6 or CasE is associated with the crRNA-Cas 
ribonucleoprotein (crRNP) effector complex, thereby coupling guide RNA biogenesis with target 
degradation, is currently not known. In fact, there are very few details about the identity and 
mechanism of the crRNP complex. Finally, while recent observations in E. coli and 
Staphylococcus epidermidis implicate DNA as the CRISPR-Cas target (Brouns et al., 2008; 
Marraffini and Sontheimer, 2008), there is little direct evidence to support this. In fact, in P. 
furiosus the target appears to be RNA (Hale et al., 2009).
! Here, we show that the E. coli CRISPR-Cas system is triggered by the expression of a 
plasmid-encoded protein targeted for export by the twin-arginine translocation (Tat) pathway in 
cells that lack the DnaK molecular chaperone. Expression of this Tat substrate activated the 
CRISPR-Cas system, which resulted in specific silencing of the plasmid DNA that encoded the 
substrate. This silencing required: (i) base complementarity between genomic spacer DNA and 
the plasmid, (ii) specific targeting of the substrate to the Tat pathway, (iii) the BaeSR two-
component signal transduction system and (iv) each of the Cas enzymes (CasABCDE and Cas1–
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3). At the heart of this silencing is the CasE protein, which formed a stable ternary complex with 
CasC and CasD, and functioned as the catalytic core of the Cas system to process pre-CRISPR 
RNA into mature crRNAs.
5.1 Identification of CasE as a key component in prokaryotic gene silencing
! Previously, we observed that a reporter protein consisting of the Tat signal peptide 
derived from E. coli trimethylamine N-oxide reductase (ssTorA) fused to the green fluorescent 
protein (GFP) was undetectable following its expression in E. coli cells that lacked the molecular 
chaperone DnaK (Fig. 5.1.1B and C) (Pérez-Rodríguez et al., 2007). We initially suspected that 
the ssTorA–GFP protein was unstable in the absence of DnaK, rendering it susceptible to 
proteolytic degradation. However, Northern analysis revealed that the absence of ssTorA–GFP in 
E. coli BW25113 ΔdnaK cells was due to elimination of the encoding mRNA (Fig. 5.1.1D). 
When plasmid-encoded DnaK was provided in trans to ΔdnaK cells, cell fluorescence and 
sstorA–gfp mRNA levels returned to near wild-type (wt) levels (Fig. S1A and B).
! To identify the factor(s) responsible for disappearance of sstorA–gfp mRNA, we screened 
a mini-Tn10 transposon library in the ΔdnaK strain background to isolate suppressor mutants 
that restored ssTorA–GFP expression, and thus cell fluorescence. The isolated suppressors 
mapped to the cas operon and, in particular, to the endoribonuclease encoded by casE and the 
promoter region of the HD nuclease-helicase encoded by cas3 (Fig. 5.1.1). A ‘clean’ deletion of 
the casE gene in strain BW25113 ΔdnaK was created. As expected, cell fluorescence was 
recovered in ΔdnaKΔcasE cells expressing ssTorA–GFP (Fig. 5.1.1 and C). Fluorescence in this 
strain was attributed to stable accumulation of sstorA–gfp mRNA (Fig. 5.1.1). To ensure this 
phenotype was due to casE inactivation and not polar effects on surrounding genes, we 
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complemented the ΔdnaKΔcasE strain with a plasmid-encoded copy of CasE. Following 
expression of ssTorA–GFP, ΔdnaKΔcasE cells that had been genetically complemented with 
CasE were only weakly fluorescent (Fig. S1A) and accumulated a correspondingly low level of 
sstorA–gfp mRNA (Fig. S1B), indicating that CasE was responsible for the gene-silencing 
phenotype. Expression of an H20A variant of CasE (CasEH20A) that is incapable of pre-crRNA 
cleavage (Brouns et al., 2008) did not confer ssTorA–GFP silencing (Fig. S1A). The E. coli K12 
cas system encodes at least eight genes: cas1, cas2, cas3 and five genes designated casABCDE 
that encode the Cascade complex (Brouns et al., 2008) (Fig. 5.1.1). Individual deletion of each of 
these genes in a ΔdnaK strain background revealed that all of the other cas pathway components 
were required for the gene-silencing phenotype (Fig. S2A). It should be noted that the absence of 
DnaK was obligatory for silencing because wt and single cas mutants in the wt background all 
emitted strong fluorescence following ssTorA–GFP expression (data not shown). The 
requirement of the Cas enzymes for silencing was corroborated by stable accumulation of 
ssTorA–GFP in BL21(DE3) ΔdnaK cells (Fig. S2B), which lack the Cas enzymes (Brouns et al., 
2008) but encode two CRISPR loci (Grissa et al., 2007) with several spacers that are 
complementary to sstorA (Fig. S2C).
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!Figure 5.1.1 CasE-dependent silencing of ssTorA–GFP. (a) The CRISPR-Cas pathway of E. 
coli K12. Repeats and spacers are indicated by diamonds and rectangles respectively. Protein 
family nomenclature is described in elsewhere (Haft et al., 2005). Asterisk indicates the relative 
location of the mini-Tn10 insertion sites in casE and upstream of cas3 that were isolated by 
transposon library screening. B and C. (b) Fluorescence microscopy and (c) flow cytometric 
screening of E. coli BW25113 (wt), BW25113 ΔdnaK or BW25113 ΔdnaKΔcasE expressing 
ssTorA–GFP from pTG, as indicated. D. Northern blot of total RNA isolated from BW25113 
(wt), BW25113 ΔdnaK or BW25113 ΔdnaKΔcasE cells carrying no plasmid (−) or expressing 
ssTorA–GFP from pTG. Blot was probed using GFP-specific digoxigenin-labelled 
oligonucleotides. Experiments performed in this figure by R. Perez-Rodriguez.
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! We next investigated whether ssTorA–GFP silencing was dependent on complementarity 
between genomic spacers and plasmid-encoded sstorA. The E. coli K12 genome contains two 
CRISPR loci, the first of which is adjacent to the cas operon and includes three spacers (spacers 
1, 5 and 8) that contain sequence complementarity to different regions of sstorA (Fig. 5.1.2A). It 
is noteworthy that all of these spacers were present in the genome prior to the introduction of 
plasmid pTG; thorough sequencing of both CRISPR regions prior to and at many time points 
(ranging from 1 h to as long as 3 days) after the introduction of the pTG plasmid provided no 
evidence for the insertion of new spacers corresponding to pTG. Nonetheless, when the entire 
CRISPR locus adjacent to the Cas enzymes (Fig. 5.1.1A) was deleted in ΔdnaK cells, silencing 
of sstorA–gfp was abolished as evidenced by the restoration of fluorescence to a level that was 
nearly identical to that observed in the ΔdnaKΔcasE mutant (data not shown). This suggested 
that silencing in ΔdnaK cells was indeed CRISPR-dependent. To determine whether 
complementarity between sstorA and spacers 1, 5 and/or 8 was responsible for silencing, we 
modified plasmid-encoded sstorA with synonymous mutations that we predicted would reduce 
base pairing between the crRNA and complementary target sequence, but would not change the 
ssTorA sequence at the protein level. Two or six synonymous point mutations were introduced 
into sstorA yielding the constructs ssS5–GFP or ssS1.5.8–GFP respectively (Fig. 5.1.2A). The 
synonymous mutations did not affect expression or localization of these constructs in wt cells 
relative to unmodified ssTorA–GFP (Fig. 5.1.2B). However, following expression in ΔdnaK 
cells, only ssTorA–GFP but not ssS5–GFP or ssS1.5.8–GFP was silenced (Fig. 5.1.2B and D), 
indicating that as few as two base pair mismatches was sufficient to block silencing. These 
results indicate that ssTorA–GFP silencing is specified by sequence identity between the 
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encoding plasmid and a genomic spacer. It should be noted that despite the relatively short 
sequence matches, the complementary sequences were all GC rich (Fig. 4.1.2A).
Figure 5.1.2 Complementarity between spacer DNA and ssTorA sequence is required for 
silencing activity. A. Escherichia coli K12 spacers 1, 5 and 8 aligned with the sense strand of 
sstorA. Bold letters correspond to complementary base pairs. Numbering of sstorA corresponds 
to the bp position relative to the start codon of native E. coli TorA. Synonymous base changes 
are indicated below the sstorA sequence. The ssS5–GFP construct was created by mutating the 
C57 and C60 nucleotides in sstorA to T57 and T60 respectively. The ss1.5.8–GFP construct was 
created by further mutating ssS5–GFP as follows: G99T, G102A, G126C and G129C. B. Western 
blot of the cytoplasmic (cyt) and periplasmic (per) fractions generated from BW25113 wt cells 
expressing ssTorA–GFP, ssS5–GFP or ssS1.5.8–GFP. Blot was probed with anti-GFP antibodies, 
stripped and reprobed with anti-GroEL antibodies, where GroEL served as a fractionation 
marker. C. Flow cytometric screening of BW25113 wt and ΔdnaK cells expressing ssTorA–GFP, 
ssS5–GFP or ssS1.5.8–GFP. D. Northern blot of total RNA from BW25113 ΔdnaK cells 
expressing ssTorA–GFP, ssS5–GFP or ssS1.5.8–GFP. Blot was probed using GFP-specific 
digoxigenin-labelled oligonucleotides. Experiments performed in this figure by R. Perez-
Rodriguez.
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5.2 Reconstitution of the core Cas complex
! As all of the cas genes tested were required for silencing (Fig. S2A) and as the 
CasABCDE proteins were previously shown to copurify (Brouns et al., 2008), we next attempted 
to reconstitute the minimal E. coli Cas complex needed to process the pre-crRNAs into crRNAs. 
Each Cas protein was purified individually and most behaved as monomers in solution including 
CasE, which migrated at ∼30 kDa on the sizing column and interacted strongly with nucleic 
acids based on strong absorption at UV260 (Fig. 5.2A). CasC, on the other hand, oligomerized 
into a ∼490 kDa species. Interestingly, CasD was only soluble when coexpressed with CasC and 
the resulting complex migrated as a 105 kDa species (Fig. 5.2A) with an estimated molar ratio of 
2:1 for CasC and CasD, respectively, based on Coomassie-stained band intensities (Fig. 5.3B). 
Strong interactions were also detected between CasC and CasE, which formed a ∼1:1 molar ratio 
complex migrating at ∼832 kDa (Fig. 5.2A and C). Different reconstitution schemes confirmed 
that CasC, CasD and CasE further formed a salt-stable ternary complex that was ∼200 kDa when 
CasD was fused with an N-terminal SUMO tag (Fig. 5.2A). Solubility was reduced in the 
absence of the SUMO tag, and the ternary complex migrated as a > 600 kDa species with an 
apparent stoichiometry estimated at 6:1:1 for CasC, CasD and CasE respectively (Fig. 5.2D). 
CasC appears to be the centre of the complex as no interactions were found between CasD and 
CasE. Previously, CasA and CasB were found at substoichiometric levels in the affinity purified 
E. coli Cascade complex (Brouns et al., 2008); however, incubation of separatedly purified CasA 
with the CasCDE complex did not lead to higher complex formation under ‘physiological’ 
conditions. Only marginal interactions were observed between CasB and CasC under low-salt 
conditions, which diminished under stringent conditions. Thus, we conclude that CasA and CasB 
are not stable components of the core Cas complex. This, however, does not rule out the 
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possibility that CasA and CasB associate with the core Cas complex in a nucleic acid-dependent 
fashion. To investigate whether the molecular composition of the CasCDE complex is conserved 
phylogenetically, we carried out similar reconstitution of Thermus thermophilus Cas proteins and 
observed an identical ternary complex formed by CasCDE (data not shown). Furthermore, T. 
thermophilus CasE, which is ∼35% identical to E. coli CasE, was found to hetero-assemble with 
E. coli CasC or CasCD to form salt-stable higher complexes (data not shown). Thus, CasCDE-
containing bacteria appear to form a conserved Cas core complex in Cas system subset 2 (Brouns 
et al., 2008).
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Figure 5.2 Reconstitution of E. coli Cascade core complexes. A. Elution profile of CasC and 
CasE proteins and CasCD, CasCE, and CasCDE complexes on analytical Superdex 200 size-
exclusion column. The x- and y-axes depict elution volume and UV absorbance at 280 nm 
respectively. Nucleic acids have been removed from Cas protein/complexes on prior ion-
exchange columns. B–D. SDS-PAGE analysis of the size-exclusion fractions of the (B) CasCD, 
(C) CasCE and (D) CasCDE complexes. Experiments performed in this figure by Q. Huang and 
K. Nam.
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5.3 CRISPR RNA processing by core Cas complex
! To reveal the function of the individual Cas proteins or Cas complexes in CRISPR RNA 
processing, we carried out in vitro RNA processing assays. Previous studies showed that pre-
crRNA processing into unit length in E. coli requires a subset of Cas proteins, especially a 
catalytically competent CasE (Brouns et al., 2008; Carte et al., 2008). CasE-mediated processing 
involves an invariable cleavage site at the base of the 5" hairpin structure to release the mature 
crRNA and a variable cleavage site at three to four different positions in the vicinity of the 
hairpin loop that may be due to the non-specific action of cellular ribonucleases (Brouns et al., 
2008; Carte et al., 2008). Here, a HEX-labelled CRISPR RNA containing the conserved CRISPR 
repeat was used as substrate. When individually purified Cas proteins were incubated with this 
5"-HEX-labelled CRISPR RNA, only CasE showed strong RNase activity (data not shown). By 
comparison with the alkaline hydrolysis ladder on sequencing gels, we determined that CasE 
cleaved at the base of the CRISPR stemloop (Fig. 5.3), coinciding with the invariable cleavage 
site that defines the 5" end of the processed crRNA (Brouns et al., 2008). This activity is specific 
for CasE as it disappeared when the CRISPR RNA was incubated with the CasEH20A catalytic 
mutant (Fig. 5.4). We then carried out a more thorough analysis of the cleavage products 
produced by CasCE and the CasCDE complexes (in which CasD is N-terminally tagged with 
SUMO). Both of these complexes were shown to generate the same cleavage pattern on the 
CRISPR repeat RNA as the CasE protein alone (Fig. 5.3). The enzymatic activity again came 
from CasE, as CasCEH20A was unable to cleave the CRISPR repeat RNA. These results suggested 
that formation of higher order complexes did not alter the enzymatic specificity of CasE protein. 
We also verified that the cleavage patterns of the SUMO-tagged complex and untagged CasCDE 
complex, which migrated as a large oligomeric species, were identical in our assay conditions 
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(data not shown) thus eliminating the possibility that the N-terminal SUMO tag in CasD altered 
the enzymetic specificity of the CasCDE complex. We cannot, however, rule out the possibility 
that the oligomeric form of the CasCDE complex is more efficient in processing the multimeric 
form of the pre-CRISPR RNA because of more efficient substrate binding.
Figure 5.3 RNase activity of Cas proteins and CasE-containing complexes. Cleavage profile 
of CasE, CasCE, CasCEDSUMO, CasEH20A, CasCEH20A and CasC alone resolved on 18% 
sequencing gel. The amount of protein used in the assay was from left to right 2.5, 0.5 and 
0.1 µM. Alkaline hydrolysis ladder in lanes 1 and 20 resolves the position of every base on the 
18% sequencing gel. Experiments performed in this figure by Q. Huang and K. Nam.
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5.4 Cas-mediated ssTorA–GFP silencing occurs via targeting of plasmid DNA
! We next investigated whether plasmid pTG encoding ssTorA–GFP was targeted by the 
Cas machinery in ΔdnaK cells. Following induction of ssTorA–GFP, we purified plasmid pTG 
from an equivalent number of wt, ΔdnaK and ΔdnaKΔcasE cells and performed restriction 
analysis on the isolated plasmids. Plasmid pTG was stably maintained in wt and ΔdnaKΔcasE 
cells but was hardly detectable in ΔdnaK cells (Fig. 5.4A). Silencing of pTG in ΔdnaK cells was 
dependent on the sstorA–gfp sequence because empty pTrc99A plasmid accumulated at a similar 
level in all strains including ΔdnaK cells (Fig. 5.4A). We reasoned that plasmid silencing would 
cause a measurable decrease in antibiotic resistance conferred by the ampR gene encoded 
elsewhere on pTG. Indeed, the minimum inhibitory concentration (MIC) on ampicillin (Amp) of 
wt and ΔdnaKΔcasE cells was eightfold and sixfold greater than that for ΔdnaK cells 
(Fig. 5.4B). To verify that the Cas machinery only targets plasmid DNA and not ‘self’ DNA, we 
determined the viability of wt, ΔdnaK and ΔdnaKΔcasE cells by plating on non-selective 
medium following ssTorA–GFP induction. The colony-forming units (cfu) of ΔdnaK cells 
expressing ssTorA–GFP was actually slightly greater than the cfu of wt and ΔdnaKΔcasE cells 
(Fig. 5.4C), indicating that E. coli Cas effector complexes specifically target extrachromosomal 
DNA while avoiding genomic DNA. To test whether the Cas complex itself is capable of plasmid 
degradation, we measured the DNase activity of CasE, CasCE and CasCEDSUMO against single- 
and double-stranded DNA oligos, and against supercoiled plasmids including pTG encoding 
ssTorA–GFP and an unrelated pUC19 plasmid. Under our experimental conditions, neither CasE, 
nor the CasE-containing complexes had any measurable DNase activity (data not shown).
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Figure 5.4 Plasmid DNA is the target of CRISPR-Cas interference. A. RsaI restriction 
analysis of plasmid DNA isolated from BW25113 wt, ΔdnaK and ΔdnaKΔcasE cells 
transformed with either pTG expressing ssTorA–GFP or empty pTrc99A (control) as indicated. 
B. Selective plating of BW25113 wt, ΔdnaK and ΔdnaKΔcasE cells expressing ssTorA–GFP. 
An equivalent number of cells was plated on LB agar with no Amp (− Amp) or supplemented 
with 50, 100 and 200 µg ml−1 Amp. C. Viability of the same cells as in (B). The number of cfu 
was determined by plating an equivalent number of induced cells on LB agar with no antibiotics. 
Experiments in this figure performed by R. Perez-Rodriguez.
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5.5 Cas-mediated silencing depends on the BaeSR two-component signal transduction system
! We next sought to determine how the CRISPR-Cas system was activated in ΔdnaK cells. 
As GFP expressed without a Tat export signal is not silenced in cells that lack DnaK (Pérez-
Rodríguez et al., 2007), targeting of GFP to the Tat translocase is a requisite for Cas-mediated 
silencing in ΔdnaK cells. Indeed, when the twin arginines in the Tat signal peptide of ssTorA–
GFP were replaced with twin lysines [TorA(R11K:R12K)], amino acid substitutions that abolish 
Tat-dependent GFP export (DeLisa et al., 2002), no silencing of ssTorA–GFP was observed in 
ΔdnaK cells (Fig. 5.5A and B). Likewise, there was also no measurable silencing when export-
competent ssTorA–GFP was expressed in ΔdnaK cells that also lacked the TatC translocase 
component, which is required for export (Fig. 5.5A and B).
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Figure 5.5 CRISPR-Cas silencing is dependent on membrane targeting and the BaeSR two-
component stress response system. A. Flow cytometric screening of BW25113 wt, ΔdnaK and 
ΔdnaKΔtatC cells expressing either ssTorA–GFP or ssTorA(KK)–GFP as indicated. B. Northern 
blot analysis of total RNA from the same cells as in (A). Blot was probed using GFP-specific 
digoxigenin-labelled oligonucleotides. C. Flow cytometric screening of BW25113 wt, ΔdnaK, 
ΔdnaKΔbaeS and ΔdnaKΔbaeR cells expressing ssTorA–GFP. D. Electrophoretic mobility shift 
assay for BaeR binding to the Cas promoter region. A total of 0.15 pmol of DNA fragments 
corresponding to cas3 (415 bp) and casA (1057 bp) promoter regions was incubated without 
(−BaeR) or with various concentrations of phosphorylated BaeR-His6. The amount of BaeR was 
from left to right 9.2, 11.5, 16.1, 24.2 and 32.25 µM. Experiments performed in this figure by R. 
Perez-Rodriguez and C. Haitjema.
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!! Based on these findings, we hypothesized that membrane localization of the highly 
expressed ssTorA–GFP fusion in ΔdnaK cells might induce an envelope stress, perhaps because 
of mislocalization of GFP in the inner membrane in these cells. We further speculated that signal 
transduction pathways that control the adaptive response to envelope stresses in E. coli might 
activate the expression of cas genes. If this interpretation is correct, then we would predict little 
to no cas gene expression, and thus no silencing activity, following ssTorA–GFP expression in 
cells where envelope stress response systems are compromised. To test this, we investigated the 
BaeSR two-component regulatory system, which includes a membrane-localized histidine kinase 
BaeS that senses envelope stress and modulates the phosphorylation state of the cytoplasmic 
transcription factor BaeR (MacRitchie et al., 2008). We focused our attention on this signalling 
pathway because overexpression of BaeR was previously shown to activate the promoter of the 
casA gene (Baranova and Nikaido, 2002). In support of our hypothesis above, we observed 
stable accumulation of ssTorA–GFP fluorescence in ΔdnaK cells that also lacked BaeS or BaeR 
(5.5C).
! As BaeSR was genetically involved in transmitting the envelope stress caused by 
ssTorA–GFP expression, we next investigated whether the BaeR regulator was able to bind cas 
promoter DNA. Recently, DNase I footprinting studies identified the BaeR-box sequence 
TCTNCANAA, where N is any nucleotide (Yamamoto et al., 2008). Our own inspection of the 
cas operon revealed a putative BaeR-box sequence of TCTGCATAA within the coding region of 
casA (nucleotides 298–306) and upstream of casBCDE. To determine whether BaeR was capable 
of binding this sequence, we performed electrophoretic mobility shift assays using purified BaeR 
and a 1057 bp DNA fragment covering the BaeR-box sequence. Two additional 358 and 415 bp 
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DNA fragments upstream of casA and cas3 were also tested as candidate BaeR binding regions. 
As a positive control, a 279 bp fragment including the acrD promoter, a known binding target of 
BaeR (Hirakawa et al., 2005), was used. BaeR-His6 protein was purified and phosphorylated 
with acetylphosphate. The electrophoretic mobility of the DNA fragments corresponding to the 
acrD promoter region (data not shown) and the BaeR-box sequence internal to casA (Fig. 5.5D) 
shifted upon the addition of phosphorylated, but not unphosphorylated, BaeR. In contrast, no 
interaction was observed between phosphorylated BaeR-His6 and the DNA fragments derived 
from regions upstream of casA (data not shown) or cas3 (5.5D). Thus, complexes formed by 
BaeR-His6 and the BaeR-box sequence internal to casA detected in this experiment were specific.
5.6 Induction of cas genes in ΔdnaK cells expressing ssTorA–GFP
! We next determined how different mutations in the chromosome affected cas gene 
expression when ssTorA–GFP was induced. As expected, upregulation of casD and casE was 
observed following ssTorAGFP expression in ΔdnaK cells but not wt cells as determined by 
quantitative reverse transcription polymerase chain reaction (qRT-PCR; Fig. 5.6). It should be 
noted that in dnaK mutants, casD and casE expression was induced 15 min after ssTorA–GFP 
expression (Fig. 5.6) but returned to uninduced levels by 2 h after ssTorA–GFP expression (data 
not shown), indicating that cas gene expression is turned off once the envelope stress caused by 
pTG is eliminated by CRISPR-Cas silencing. However, similar stress adaptation was not 
observed in a ΔdnaKΔcasE double mutant. In these cells, casD expression remained elevated as 
long as 2 h after induction of ssTorA–GFP (data not shown), suggesting that the lack of pTG 
silencing in these cells results in a sustained stress and a corresponding sustained induction of the 
Cas pathway. Importantly, the induction of both casD and casE was abolished in ΔdnaKΔbaeR 
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or ΔdnaKΔbaeS double mutants (Fig. 5.6), indicating that the BaeSR pathway is required for 
induction of the cas genes in response to ssTorA–GFP expression in ΔdnaK cells. This result is 
entirely consistent with our observation above that BaeS and BaeR are each required for plasmid 
silencing. As upregulation of cas gene expression depended on BaeSR, we speculated that genes 
whose induction is mediated by the BaeSR pathway, such as spy (Raffa and Raivio, 2002), might 
also be upregulated in ΔdnaK cells expressing ssTorA–GFP. In line with this hypothesis, we 
observed that spy expression was induced in ΔdnaK cells expressing ssTorA–GFP (Fig. 5.6). As 
was seen for casD and casE, mutation of baeR or baeS eliminated the elevated spy expression 
that was seen in the ΔdnaK strain expressing ssTorA–GFP (Fig. 4.6). However, spy expression 
was diminished in ΔdnaKΔcasE cells, indicating that the stress caused by expression of ssTorA–
GFP in cells where silencing is absent was not a trigger of the BaeSR response. Hence, we 
conclude that the requirement for the Bae response in cells carrying the induced sstorA–gfp and a 
ΔdnaK mutation is complex and involves additional factors, beyond a simple sstorA–gfp-
mediated upregulation of the Bae response.
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Figure 5.6 Induction of cas pathway in response to ssTorA–GFP envelope stress. Expression 
of casD (light gray bars), casE (dark gray bars), spy (black bars) and sstorA–gfp (white bars) as 
determined by qRT-PCR analysis. Total RNA was isolated 15 min after induction of ssTorA–
GFP from each of the strains indicated. All data were normalized to the amount of 16S rRNA 
measured in each strain. Relative induction was then calculated by the comparative Ct method 
using the values measured in wt cells expressing ssTorA–GFP as calibrators. It should be noted 
that the expression levels of sstorA–gfp measured in these qRT-PCR experiments were entirely 
consistent with our Northern blot and cell fluorescence analysis. Experiments performed in this 
figure by C. Haitjema.
!
! We next examined whether other known Bae inducing cues triggered upregulation of the 
Cas pathway. Specifically, we tested whether induction of casD and CasE expression was 
observed in response to spheroplasting and separately, to the formation of misfolded pilin 
subunits caused by PapG overexpression. Both of these stresses are well known to activate the 
Bae signal transduction pathway (Raffa and Raivio, 2002). However, we found no evidence for 
casD or casE induction in response to either of these envelope stresses under the conditions 
tested here (data not shown).
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5.7 Functional reconstitution of ssTorA–GFP silencing in cas-deficient E. coli
! Finally, we speculated that overexpression of the Cas enzymes from an inducible 
promoter would bypass the BaeSR-dependent cas regulation and produce silencing in a manner 
that did not require DnaK. BL21(DE3) cells were used to test this notion because they lack 
genomic copies of the cas genes but contain CRISPR loci that encode several spacers with 
complementarity to sstorA. Indeed, coexpression of the entire cas operon from pWUR399 
(Brouns et al., 2008) along with ssTorA–GFP in BL21(DE3) led to elimination of ssTorA–GFP 
in both the presence and absence of DnaK (Fig. S2B). This silencing was abolished when an 
H20A substitution was introduced to casE in pWUR399 (data not shown). Consistent with their 
role as a minimal RNA processing unit, coexpression of the CasCDE enzymes from pWUR402 
was insufficient to produce silencing in this system (Fig. S2B). This result indicates that 
additional enzymes, perhaps from the set of CasA, CasB, Cas1, Cas2 and Cas3, are required for 
silencing and is in line with our single-gene knockout studies in K12 E. coli (Fig. S2A). The 
ability to functionally reconstitute ssTorA–GFP silencing in BL21(DE3) cells by simple addition 
of cas genes should enable further dissection of this unique mechanism.
5.8 Cas5d, together with Csd1 and Csd2, complements Cas-deficient E. coli to silence plasmid 
DNA in vivo.
! Like E. coli, it was recently identified that Bacillus halodurans C-125 also encodes a 
CRISPR-Cas system, albeit of the Dvulg subtype. Among the Cas enzymes in the B. halodurans 
CRISPR-Cas system is the Cas5d enzyme, which, like E. coli Cas5e (CasD), belongs to the Cas5 
family of proteins. The B. halodurans also encodes Csd1 and Csd2 which are predicted to be the 
functional analogs of E. coli CasA and E. coli CasC, respectively. Thus, we asked the question 
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whether these B. halodurans enzymes can complement the activity of their predicted E. coli 
counterparts.  To test the in vivo activity of Cas5d and the newly identified Dvulg-Cascade 
complex, we utilized a previously established fluorescence-based genetic reporter of CRISPR-
Cas interference in E. coli (Perez-Rodriguez et al., 2011). In this earlier study, we observed that 
GFP targeted to the twin-arginine translocation (Tat) pathway induced the CRISPR-Cas system 
in E. coli cells lacking the molecular chaperone DnaK. Activation of this CRIPSR-Cas response 
was dependent on the BaeSR two-component signaling pathway, which is typically involved in 
cell envelope stress responses. As a result, plasmid DNA encoding the Tat-targeted GFP reporter, 
namely ssTorA-GFP, was silenced and GFP fluorescence was abolished. This silencing 
phenotype required each Cas protein (i.e., Cascade and Cas1-3) and the genomic CRISPR region 
adjacent to the Cas operon; deletion of any of these components abolished the plasmid silencing. 
For example, silencing-competent ∆dnaK cells expressing ssTorA-GFP were virtually non-
fluorescent but when the gene encoding one of the Cas proteins, such as CasA (Cse1), CasB 
(Cse2), CasC (Cse4), CasD (Cas5e), or CasE (Cse3) was deleted, silencing activity was 
abolished and cells became highly fluorescent (Fig. 5.8). Using this genetic system, we attempted 
to complement the different E. coli Cas mutants with the functional or sequence homolog from 
B.halodurans, namely Csd1 for CasA, Csd2 for CasC, and Cas5d for CseD and CasE. Only the 
B.halodurans Csd2 enzyme was able to restore silencing activity to the corresponding CasC 
mutant E. coli strain (Fig. 5.8). Interestingly, simultaneous coexpression of Cas5d, Csd1, and 
Csd2 resulted in a strong silencing phenotype in all of the mutant strain backgrounds (Fig. 5.8), 
consistent with our biochemical reconstitution data showing that these proteins form a Cascade 
like assembly. Based on our study, the E. coli pre-crRNA is expected to be a poor substrate for B. 
halodurans Cas5d. However, the residual processed crRNA may be sufficient to render plasmid 
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silencing together with the overexpressed B. halodrans Cascade. Taken together, these results 
suggest that the Dvulg-Cascade complex formed in vivo is functionally active, using 
extrachromosomal DNA as the target.
Figure 5.8 Cas-dependent silencing of ssTorA-GFP in E. coli. Cellular fluorescence of wild-
type (wt) E. coli BW25113, BW25113 ΔdnaK, and isogenic cas mutant strains (e.g., BW25113 
ΔdnaKΔcasE) expressing ssTorA-GFP from plasmid pTG. Complementation of silencing 
activity was assayed using pBhCsd1, pBhCsd2, pBhCas5d or pBhCascade (Cas5d/Csd1/Csd2) 
and compared to the empty vector (pBAD33) control. Data is the average of three replicate 
experiments and error is reported as the standard error of the mean. Experiments performed in 
this figure by C. Haitjema.
5.9 Discussion
! Previous studies have firmly established that CRISPR-Cas systems protect bacteria by 
conferring immunity against bacteriophage infection (Barrangou et al., 2007; Brouns et al., 2008) 
and limiting plasmid conjugation (Marraffini and Sontheimer, 2008). Here, we made the 
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unexpected discovery that membrane localization of ssTorA–GFP in ΔdnaK cells activated the 
Cas pathway and led to silencing of the ssTorA–GFP-encoding plasmid. At present, the reason 
for Cas activation following ssTorA–GFP expression in ΔdnaK cells is poorly understood. The 
Tat system exports proteins that have undergone folding in the cytoplasm (Sanders et al., 2001; 
DeLisa et al., 2003)by inserting these folded substrates into the inner membrane (Hou et al., 
2006). However, when aberrantly folded proteins are targeted to the Tat system, cells exhibit 
severe growth defects that are likely due to proton leakage at the membrane (Richter and Brüser, 
2005). Hence, we speculate that the absence of the DnaK chaperone, which is known to assist the 
folding and translocation of certain Tat substrates (Oresnik et al., 2001; Perez-Rodriguez et al., 
2011), resulted in misfolding and/or mislocalization of ssTorA–GFP in a manner that disrupted 
membrane integrity or was otherwise toxic to cells. The subsequent activation of CRISPR-Cas 
suggests that this system may provide a defence mechanism against defective protein localization 
that threatens the integrity of the inner cytoplasmic membrane. It is worth mentioning that we 
have not been able to find any evidence for the acquisition of new genomic spacers derived from 
plasmid pTG. Instead, the spacers targeting sstorA were encoded in existing genomic spacers. 
Whether preexisting spacers result in CRISPR-mediated silencing of endogenous torA or any 
other endogenous proteins is currently unclear. However, it seems unlikely that torA silencing is 
a conserved mechanism given the enormous variety in CRISPR spacers (Díez-Villaseñor et al., 
2010).
! Nonetheless, our results represent the first evidence for the induction of CRISPR-Cas 
activity by a cue other than phage infection or plasmid conjugation (Barrangou et al., 2007; 
Brouns et al., 2008). While these cues are different, they are known to elicit overlapping stress 
responses (MacRitchie et al., 2008). Thus, we speculate that activation of CRISPR-Cas in 
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response to defective protein export, phage infection and plasmid conjugation may be mediated 
by the same (or overlapping) stress sensing mechanisms (Fig. 5.9). In this study, ssTorA–GFP 
silencing in ΔdnaK cells was dependent upon the BaeSR signal transduction pathway, indicating 
that an endogenous cellular mechanism may be involved in the CRISPR-Cas defence system. 
Such regulated control of Cas enzyme expression is probably needed because constitutive 
expression of these potent RNases and DNases would be detrimental to the fitness of the host. In 
fact, recent evidence indicates that cas gene expression is strongly repressed by the nucleoid-
associated protein H-NS (Pul et al., 2010), a protein known to silence transcription of laterally 
acquired genes. H-NS downregulates cas expression by binding to a promoter located upstream 
of the casA gene and its repression is proposed to be released by anti-silencing mechanisms, 
which allow the cell to express the genes under specifically regulated conditions. One such anti-
silencing mechanism involves the transcriptional activator LeuO (Westra et al., 2010). We show 
here that another possible anti-silencing mechanism involves the BaeSR two-component 
regulatory system. Following induction of stress by ssTorA–GFP expression, activated BaeR 
may promote release of H-NS-mediated cas repression by binding to a newly identified promoter 
sequence (TCTGCATAA) that is located within the coding region of casA and downstream of the 
cas promoter where H-NS binds. It should be noted that while activation of the cas pathway 
minimally involves BaeSR, we cannot rule out the involvement of additional envelope stress 
response pathways that may work to cooperatively combat envelope stress by triggering 
CRISPR-Cas. Psp response is a likely candidate because it can be induced in E. coli upon 
filamentous phage infection (specifically phage secretin pIV) and by other membrane-damaging 
agents (Model et al., 1997), and it has been implicated in mitigating the stress associated with 
highly expressed Tat substrates (DeLisa et al., 2004).
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Figure 5.9 Model of CRISPR RNA-mediated DNA silencing in E. coli. Following an attack 
by a phage or the aberrant expression of a secreted or membrane protein, envelope stress 
response systems, such as the two-component BaeSR signal transduction pathway, are activated. 
An activated response regulator, for instance phosphorylated BaeR (BaeR-P), triggers expression 
of the Cas proteins and perhaps also the transcription of full-length CRISPR RNA. Full-length 
CRISPR RNA is recognized by the CasCDE core complex and processed to produce small guide 
RNAs (crRNAs), which have a uniformly processed 5" end and a variable 3" end. CasE or 
perhaps the entire CasCDE ternary complex remain associated with the processed crRNAs and 
may be guided to the target DNA to initiate DNA degradation. Whether CasCDE is a landmark to 
attract other effector proteins such as CasA and CasB through transient interactions is currently 
unclear but additional enzymes are necessary as CasE or CasE-containing complexes do not 
exhibit any measurable DNase activity. Nonetheless, silencing by the Cas effector complex is 
achieved by base pairing between the crRNA and the DNA target, which may occur during active 
replication of phage genome or plasmid DNA. Finally, a small number of bacteria acquire new 
spacers derived from the foreign DNA (marked by an asterisk), leading to survival by CRISPR 
RNA-mediated degradation of DNA.
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!! Once activated, the CasABCDE proteins reportedly form a complex called Cascade, 
where the CasE protein within the complex is responsible for processing full-length CRISPR 
RNA (Brouns et al., 2008). Here we confirmed that CasE is sufficient for pre-CRISPR RNA 
processing, and that CasE is involved in the formation of a ternary CasCDE core complex that 
further oligomerizes to form a larger molecular assembly. A mechanistic model can therefore be 
generated to summarize our data, in which we hypothesize that by assuming a defined tertiary 
structure, the oligomeric CasCDE core complex possesses greater affinity for multimeric 
CRISPR repeat regions than individual Cas proteins. This in turn allows more efficient pre-
CRISPR processing by CasE. Structure determination of the CasCDE core architecture and its 
interactions with the CRISPR repeat sequence will be critical for further understanding the pre-
CRISPR processing mechanisms.
! In addition to E. coli K12, we have also observed a CasCDE core in B. halodurans and T. 
thermophilus (data not shown), suggesting that the pre-CRISPR processing complex is 
minimumly conserved in Cas System 2 (CASS2). As CasCD pairs have been identified in five 
out of the seven categorized CASS subtypes (Makarova et al., 2006), we speculate that these two 
proteins, especially CasC, likely play an important role in organizing the formation of the 
Cascade complex. However, it should be noted that the other three Cascade proteins, CasA, 
CasB and CasE, are not well conserved among CASS subtypes (Makarova et al., 2006). CRISPR 
repeat sequences and their predicted secondary structures can also differ significantly between 
organisms (Grissa et al., 2008). Therefore, the pre-CRISPR processing factor in CasE-deficient 
organisms may differ from that in E. coli. Cas6 is found in many CasE-deficient organisms (Haft 
et al., 2005). Despite sharing little sequence homology, CasE and Cas6 adopt a common 
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duplicated ferredoxin fold and catalyse metal-independent RNA cleavage (Carte et al., 2008). It 
remains to be determined whether Cas6 can interact with CasCD in these organisms. Moreover, 
some bacteria encode neither CasE nor Cas6 in their CRISPR-Cas system. For example, single 
ferritin fold containing Csy4 protein from Pseudomonas aeruginosa was shown to carry out pre-
CRISPR processing in a sequence specific fashion (Haurwitz et al., 2010). Therefore, the pre-
CRISPR processing mechanism likely varies among CASS subtypes, underlining the diversity of 
CRISPR-Cas systems.
! While it is now clear that the induction of cas gene expression results in the formation of 
CasCDE, which promotes the maturation of the crRNAs, the recognition and degradation of the 
foreign target occurs by mechanisms that remain poorly understood. Once generated, crRNAs 
use base pairing to presumably guide a crRNP complex to the invasive target. In our studies, 
disruption of perfect base pairing by as few as two mutations was sufficient to abrogate silencing. 
This is consistent with earlier studies showing that even a single spacer/target mismatch 
compromises CRISPR interference (Barrangou et al., 2007; Deveau et al., 2008; Marraffini and 
Sontheimer, 2008). For instance, of 19 phages that evolved to evade CRISPR targeting in 
Streptococcus thermophilus, eight contained a single mutation and three contained a double 
mutation (Deveau et al., 2008). A surprising aspect of our studies was the relatively short (∼8–11 
base pairs) spacer/target complementarity that was required for silencing. Given the short lengths 
of these matches, equilibrium hybridization thermodynamics would seem to be insufficient for 
discrimination between plasmid DNA and random genomic targets, suggesting that an additional 
layer of target ‘sensing’ is performed by the CRISPR-Cas machinery. One example of such an 
additional layer is the observation that differential complementarity outside of the spacer 
sequence is an in-built feature of CRISPR systems for self (spacer DNA within the encoding 
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CRISPR locus itself) versus non-self discrimination (Marraffini and Sontheimer, 2010). 
Accumulated evidence points to DNA as the target for CRISPR-mediated degradation in E. coli 
(Brouns et al., 2008) and S. epidermidis (Marraffini and Sontheimer, 2008); however, recent 
studies of P. furiosus raise the possibility that some CRISPR-Cas systems target RNA (Hale et 
al., 2009). This functional difference seen for P. furiosus may be due to the presence of a Cas 
repeat-associated mysterious protein module, which contains six genes, cmr1–cmr6, that are 
absent in numerous prokaryotes including E. coli and S. epidermidis (Haft et al., 2005; Makarova 
et al., 2006). Our own studies suggest that plasmid DNA is the intracellular target of the E. coli 
CRISPR-Cas system; however, whether the Cas enzymes alternatively target the RNA of a factor 
required for plasmid replication, segregation and/or maintenance cannot be ruled out. Hence, a 
key issue moving forward is to definitively prove whether Cas enzymes silence DNA and/or 
RNA in E. coli. Based on the observation that mature crRNAs remain associated with P. furiosus 
Cas6 (Carte et al., 2008) and the E. coli CasCDE complex (our unpublished observations), we 
speculate that the same complex may participate directly in target degradation. One possibility 
for DNA targets is that active replication of phage genome or plasmid DNA allows a window of 
opportunity for crRNA to base pair with the single-stranded target DNA. Such a mechanism is 
reminiscent of eukaryotic RNAi, in which Argonaute2 retains one strand of the small interfering 
RNA (siRNA) as the guide to base pair and cleave target mRNAs (Liu et al., 2004). While the 
composition of the in vivo crRNP effector complex remains a mystery, our genetic screen 
showed that Cas1, Cas2, Cas3 and all five Cascade proteins are required for ssTorA–GFP 
silencing in a ΔdnaK strain background. Biochemically only the CasCDE enzymes were 
required in CRISPR processing but they did not exhibit any measurable DNase activity. Thus, 
given that E. coli Cas1 and Cas2 function upstream of the CRISPR processing and DNA 
90
targeting stages (Brouns et al., 2008), it follows that CasA, CasB and/or Cas3 may participate in 
the downstream effector stage (Fig. 4.9). We also cannot rule out the participation of other 
enzymes that may be encoded outside of the cas operon. We are currently investigating whether 
the CasCDE complex serves as a landmark to attract effector proteins through transient 
interactions (Fig. 5.9).
5.10 Materials and methods
5.10.1 Bacterial strains, plasmids and growth conditions
! Escherichia coli strain BW25113 (lacIq rrnBT14 ΔlacZWJ16 hsdR514 ΔaraBADAH33 
ΔrhaBADLD78) and single-gene knockout mutants of BW25113 from the Keio collection (Baba et 
al., 2006) were used for all experiments unless otherwise noted. BW25113 ΔdnaK double 
knockout strains were created by P1vir phage transduction. Briefly, kanamycin (Kan)-marked 
alleles derived from single-gene knockout strains from the Keio collection were transduced in 
recipient BW25113 ΔdnaK cells that had the Kan resistance marker in dnaK eliminated as 
described (Datsenko and Wanner, 2000). The CRISPR deletion strain was made by generating a 
Kan-marked deletion in BW25113 ΔdnaK cells as described (Datsenko and Wanner, 2000). 
BL21(DE3) [F-ompT hsdSB (rB− mB−) gal dcmλ(DE3)] (Novagen) or T7 Express lysY (New 
England Biolabs) cells were used as hosts for expression of the BaeR and Cas enzymes 
respectively.
! Strains were routinely grown aerobically at 37°C in Luria–Bertani (LB) medium, and 
antibiotics were supplemented at the following concentrations: Amp, 100 µg ml−1; Kan (5 µg ml
−1); spectinomycin (Spec, 50 µg ml−1); tetracycline (Tet, 10 µg ml−1). Protein synthesis was 
induced when the cells reached an absorbance at 600 nm (Abs600) of ∼0.5 by adding 0.2% 
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arabinose and/or 1 mM isopropyl-β-d-thiogalactopyranoside (IPTG) to the media. For silencing 
experiments, protein synthesis was induced for 4–6 h prior to characterizing cellular fluorescence 
or harvesting plasmid DNA, total mRNA and total proteins.
5.10.2 Plasmids
! Plasmid pTG encoded the E. coli ssTorA signal peptide fused to GFP in pTrc99A (Pérez-
Rodríguez et al., 2007) and pTrc–GFP encoded GFP cloned in pTrc99A (Amann and Brosius, 
1985). For dnaK genetic complementation studies, BW25113 Δdnak cells were transformed with 
pOFXbad-KJ2, which encodes dnaK and dnaJ under control of the pBAD promoter (Castanié et 
al., 1997). For casE genetic complementation studies, BW25113 ΔdnakΔcasE cells were 
transformed with pOFXbad–casE, which encodes casE under control of the pBAD promoter. 
Synonymous mutations in the ssTorA signal peptide were created using site-directed mutagenesis 
(QuikChange® II Site-Directed Mutagenesis Kit, Stratagene) according to manufacturer's 
protocols. Plasmid pssS5–GFP was created by mutating the C57 and C60 nucleotides in sstorA to 
T57 and T60 respectively. Plasmid pss1.5.8–GFP was created by further mutating pssS5–GFP as 
follows: G99T, G102A, G126C and G129C. Similarly, plasmid pTorA(KK)–GFP was created by 
mutating the consensus twin-arginine residues in the ssTorA signal peptide to twin-lysine 
residues using site-directed mutagenesis. For protein purification, CasC, CasE and CasEH20A 
were PCR amplified from E. coli K12 genomic DNA and cloned into pET-21a(+) (Novagen) 
with an N-terminal His6-tag. CasA, CasB, CasD, Cas1 and Cas3 were cloned into the pQE-80 
vector (Qiagen) with an N-terminal His6-tag. Cas2 was cloned in pGEX-4T-1 (GE Healthcare) to 
generate a GST fusion. Additional plasmids used in Cas protein coexpression studies included: 
CasC cloned in the pCDFDuet-1 vector (Novagen) without any affinity tag, CasD cloned into the 
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pSUMO vector with an N-terminal His6-SUMO tag and CasE cloned in pET-29b(+) (Novagen) 
without any affinity tag. CasEH20A was constructed using Phusion Site-Directed Mutagenesis Kit 
(New England Biolabs). BaeS and BaeR were cloned in pET-21a(+) (Novagen) with a C-
terminal His6-tag. For cas complementation studies, plasmid pWUR399, pWUR402 (Brouns et 
al., 2008) or pWUR399(CasEH20A) was cotransformed in strain BL21(DE3) along with pTG and 
induced using IPTG. Plasmid pWUR399(CasEH20A) was created by site-directed mutagenesis of 
plasmid pWUR399.
5.10.3 Generation of transposon library and mapping of insertions
! An initial mini-Tn10 transposon insertion mutant library was generated by tranducing E. 
coli NLL51, an MC4100 recA− derivative, to tetracycline resistance using a population of 
lambda phage that carried mini-Tn10 inserts as described previously (Takiff et al., 1989). The 
initial mini-Tn10 insertion library contained 4.2 × 104 transductants, representing ∼10-fold 
coverage of the genome. This library was then transduced in ΔdnaK cells carrying pTG by P1vir 
phage transduction and 3.0 × 104 clones were recovered on LB-Tet/Amp plates, for 
approximately eightfold coverage of the genome. To isolate highly fluorescent clones, library 
cells were grown overnight, subcultured and induced for 4–6 h. Induced library cells were 
diluted 200-fold in 1 ml of phosphate-buffered saline (PBS, pH 7.4) and sorted using a 
FACSCalibur flow cytometer (Becton Dickinson Biosciences) as described previously (DeLisa 
and Bentley, 2002). A total of ∼1 × 106 cells were examined in 30 min, and ∼400 events were 
collected. Individual clones were re-screened via flow cytometry and a fluorescent plate reader 
(Synergy HT, BioTek Instruments) for verification of fluorescent phenotypes.
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To sequence the insertion mutations in the chromosome of positive clones, a nested PCR strategy 
was used. This entailed a first PCR reaction using genomic DNA from ΔdnaK mini-Tn10 
mutants as template, and a reverse primer (CTTTGGTCACCAACGCTTTTCCCG) specific for 
the 3" end of the mini-Tn10 insert and a forward arbitrary primer 
(GGCCACGCGTCGACTAGTACNNNNNNNNNNGCTGG) that annealed to the flanking 
chromosome. A second PCR was then performed using the PCR product from the first reaction as 
template, along with a forward primer (GGCCACGCGTCGACTAGTAC) that annealed to the 
constant portion of the arbitrary primer and a reverse primer 
(CATATGACAAGATGTGTATCCACC) that annealed to an upstream region of the mini-Tn10 
sequence. The resulting amplified DNA was gel purified and sequenced.
5.10.4 Cellular fluorescence analysis
! Overnight cultures harbouring GFP-based plasmids were subcultured into fresh LB 
medium with appropriate antibiotics and protein expression was induced in mid-exponential 
phase growth. After 4–6 h, cells were harvested by centrifugation and washed once with PBS, pH 
7.4. Next, 5 µl of washed cells were diluted into 1 ml of PBS and analysed using a FACSCalibur 
flow cytometer and CellQuest Pro software. All mean cell fluorescence data from flow 
cytometric analysis are the average of three replicate experiments (n = 3). Error bars represent 
the standard error of the mean (s.e.m.). Fluorescence microscopy was performed as described 
(Kim et al., 2008).
\
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5.10.5 RNA and protein expression analysis
! Total RNA was isolated from 10 ml of cells using the Qiagen RNeasy Mini Kit. Northern 
blots were performed as follows: 5 µg of total RNA was separated on a formaldehyde agarose 
gel, transferred to a positively charged nylon membrane by capillary elution and immobilized by 
baking the membrane. Digoxigenin-labelled oligonucleotide probes were synthesized using PCR 
amplification in the presence of digoxigenin-dUTP according to manufacturer's protocol (Roche 
Applied Sciences). Hybridizations were performed under stringent conditions (55°C in 50% 
formamide, 0.25 M sodium phosphate pH 7.2, 0.25 M sodium chloride, 7% SDS, 100 µg ml−1 
fragmented salmon sperm DNA and 5 µg ml−1 yeast tRNA). Membranes were washed and 
exposed to anti-digoxigenin antibody from mouse (diluted 1:10 000) and CDP-Star substrate 
according to manufacturer's protocol (Roche Applied Sciences). Detection was with X-ray film.
Cytoplasmic and periplasmic protein fractions were generated from 10 ml of cells using the cold 
osmotic shock procedure (Kim et al., 2005). Subcellular fractions were separated by SDS-PAGE 
using 12% Tris-HCl gels (Bio-Rad), transferred to Immobilon P (Millipore) and blotted using the 
following primary antibodies: mouse anti-GFP (Sigma; diluted 1:2 000) and mouse anti-GroEL 
(Sigma; diluted 1:20 000). Secondary antibodies were goat anti-mouse and goat anti-rabbit 
horseradish peroxidase conjugates (Promega) diluted 1:2500. Signals were detected using 
enhanced chemiluminescence (ECL) (Amersham). To verify the fractionation quality, 
membranes were first probed with primary antibodies and, following development, stripped in 
Tris-buffered saline/2% (w/v) SDS/0.7 M β-mercaptoethanol. Stripped membranes were re-
blocked and probed with anti-GroEL antibodies.
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5.10.6 Protein purification
! For biochemical studies, Cas protein expression vectors were transformed into T7 
Express lysY host cells (New England Biolabs) and expression was induced at 15°C for 20 h with 
0.3 mM IPTG. The harvested cells were lysed by sonication in lysis buffer (50 mM Tris-HCl pH 
8.5, 500 mM NaCl, 10 mM imidazole, 5 mM β-mercaptoethanol and 1 mM benzamidine 
chloride). The supernatant after centrifugation was applied onto 5 ml of Ni-sepharose column 
(Sigma) for each purification. After protein binding, the column was washed thoroughly with 100 
column volumes of lysis buffer followed by 10 volumes of lysis buffer supplemented with 
40 mM imidazole. The bound protein was eluted from the column using five column volumes of 
elution buffer (300 mM imidazole pH 7.5, 200 mM NaCl, 5 mM β-mercaptoethanol and 1 mM 
benzamidine chloride). Each purified protein was concentrated and further purified using a 
Superdex 200 size-exclusion column followed by an ion-exchange column (MonoQ or SourceS) 
(GE Healthcare). Cas2 was expressed and purified in an N-terminal GST fusion form. All of the 
purified proteins were analysed by SDS-PAGE and judged to be greater than 95% purity.
To coexpress the CasCE complex, pCDFDuet-1–CasC and pET-21–CasE were cotransformed 
into T7 Express lysY cells. Following coexpression, the CasCE complex was purified on a Ni-
sepharose column followed by a Superdex 200 sizing column and a SourceQ ion-exchange 
column on FPLC as described above. The fact that CasC copurified with His6-tagged CasE 
protein despite stringent high-salt wash suggests that these two proteins form a very stable 
complex. Following a similar strategy, we confirmed that the coexpressed CasC (from 
pCDFDuet-1–CasC) and CasD (from pQE80–CasD) proteins form a stable complex. In this case, 
a single His6-tag was introduced at the N-terminus of the CasD protein.
! To test whether a ternary complex formed between CasC, CasD and CasE, we 
cotransformed pET-29–CasE (encoding CasE without a His6-tag), pCDFDuet-1–CasC and 
pQE80–CasD (encoding CasD with an N-terminal His6-tag) into the host cell T7 Express lysY. 
Following coexpression, the CasCDE complex was purified with a Ni-sepharose column 
followed by a Superdex 200 column and a SourceQ ion-exchange column on FPLC as described 
above. An apparent stoichiometry of 2:1:2 was observed for the CasC, CasD and CasE proteins 
in the ternary complex after the above purification (data not shown). However, after extended 
incubation at 4°C and heparin column separation, the stoichiometry of the ternary complex 
shifted to 6:1:1, reflecting the tendency of CasC to oligomerize into most likely a helical 
hexamer in a dynamic fashion. Although only CasD contains a His6-tag, CasE and CasC 
copurifies with CasD under stringent purification conditions, suggesting that these three proteins 
indeed form a stable ternary complex. Because the CasCDE complex could not be satisfactorily 
separated from the CasCD complex by size-exclusion or ion-exchange chromatography, another 
coexpression system was designed in which CasD was cloned into the pSUMO vector with an N-
terminal His6-SUMO tag. The resulting CasCEDSUMO complex again copurified on the Ni-
sepharose column under stringent purification conditions, and CasCEDSUMO and CasCD were 
separated on Superdex 200 column based on their size difference.
5.10.7 RNase activity assay
! The HEX-labelled RNA substrate (5"-
GAGUUCCCCGCGCCAGCGGGGAUAAACCG-3") was purchased from Sigma. RNA and 
proteins were incubated for 30 min in a buffer containing 20 mM Tris pH 7.5, 20 mM NaCl, 
1 mM MgAc2 and 10% glycerol. The reaction mixture was combined with loading buffer at a 
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ratio of 1:9 and separated on an 18% sequencing gel. The gel was scanned with a Typhoon 9400.
5.10.8 DNase activity assay
! The ds-DNase activity was carried out in 20 µl reactions at 37°C for 2 h in a buffer 
containing 10 mM Tris-HCl pH 7.9, 50 mM NaCl, 10 mM MgCl2 and 1 mM dithiothreitol using 
0.05 g l−1 supercoiled pTG or pUC19 plasmids as substrates. The reaction was then phenol-
extracted, separated on a 0.8% agarose gel and stained with ethidium bromide. The ss-DNase 
assay was carried out in the same buffer. 5" Fluorescein-labelled 29 nt DNA oligo (fluorescein-
TCGCGCATACCCTGCGCGTCGCCGCC) at a concentration of 100 nM encoding part of 
spacer 5 was used as substrate to allow fluorescent detection. In a parallel set of experiment, this 
oligo was heat-annealed with equimolar amount of the complementary strand to assay for the ds-
DNase activity under the same conditions. The reaction mixture was separated in 18% 
sequencing gel, and the fluorescent signals were read using a Typhoon 9400 Imager. All reactions 
were carried out at 37°C with the addition of 200 nM Cas proteins/complexes.
5.10.9 Plasmid DNA restriction analysis
! Plasmid DNA was isolated from an equivalent number cells carrying either pTG and or 
empty pTrc99A (control) using a Qiagen Miniprep kit. An equal volume of plasmid DNA was 
digested with the non-unique restriction enzyme RsaI (New England Biolabs) for 4 h at 37°C. 
After removing the enzyme from the reaction using a PCR cleanup kit (Qiagen), 20 µl of each 
DNA-containing sample was mixed with loading dye (1:1) and separated on a 1% agarose gel 
pre-stained with ethidium bromide.
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5.10.10 Bacterial MIC and viability analysis
! The MIC of bacteria grown was determined by selective plating of cells on Amp. 
Overnight cultures were diluted 105-fold in liquid LB and plated on LB agar supplemented with 
increasing Amp concentrations and 0.1 mM IPTG. Reported MIC values were the average of 
three replicate experiments. The number of colony-forming units per millilitre (cfu ml−1) was 
determined as follows: overnight cultures were subcultured and induced with 1 mM IPTG after 
reaching an Abs600∼0.5. Following 4 h of induction, an equivalent amount of cells (Abs600∼1.0) 
was harvested and plated on LB agar with no antibiotics. The number of cfu ml−1 was determined 
by counting individual colonies on plates after overnight growth. Reported cfu ml−1 values were 
the average of three replicate experiments.
5.10.11 Electrophoretic mobility shift analysis
! Phosphorylated or unphosphorylated BaeR was assayed for its ability to bind putative 
Cas promoter DNA in the vicinity of the casA and cas3 genes by electrophoretic mobility shift 
analysis. Putative Cas promoter DNA in the vicinity of the casA and cas3 genes cloned from 
BW25113 wt genomic DNA by PCR using the following primers: casA forward: 
5"TAAACCGCTTTTAAAACCACCACCAAAACCT-3", casA reverse: 
5"GATGGATGGGTCTGGCAGGG-3"; cas3 forward: 
GGCATATATATTTAAAAGGTTCCATTAATAGCCTCCCTGTTTTTTTAGTA, cas3 reverse: 
GGTTACACGAAGGGTAAATATTGCCGGACAAATT. Control DNA fragments corresponding 
to the acrD (−1 to −276 bp) promoter region were similarly prepared by PCR with BW25113 
genomic DNA as a template. Separately, BaeR-His6 was expressed in BL21(DE3) cells from 
pET-21–BaeR and purified using a Ni-sepharose column (Qiagen). Purified BaeR-His6 was 
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phosphorylated using 50 mM acetylphosphate in a buffer containing 100 mM Tris (pH 7.4), 
10 mM MgCl2 and 125 mM KCl. The protein was incubated in this buffer for 1 h at 30°C. Next, 
0.15 pmol of DNA was mixed with varying amounts (9.2, 11.5, 16.1, 24.2 and 32.25 µM) of the 
phosphorylated protein in a 20 µl reaction containing 100 mM Tris (pH 7.4), 10 mM MgCl2, 
100 mM KCl, 10% glycerol and 2 mM dithiothreitol. The reaction mixture was incubated for 
20 min at room temperature and the samples were electrophoresed on a 10% Tris-Borate-EDTA 
(TBE) gel (Bio-Rad) in TBE buffer at 4°C. The gel was then soaked in a 1:10 000 dilution of 
SYBR-Gold stain (Invitrogen) and the DNA was imaged under UV light using a Gel Doc 2000 
(Bio-Rad).
5.10.12 Analysis of gene expression by qRT-PCR
! Quantitative reverse transcription polymerase chain reaction analysis of cas, spy, and 
sstora-gfp gene transcript abundance was performed similar to that described elsewhere (Westra 
et al., 2010). Briefly, cDNA was synthesized using Omniscript RT Kit (Qiagen) from RNA 
extracted using the RNeasy Mini Kit (Qiagen) and DNase I-treated using RNase-free DNase Set 
(Qiagen). The qRT-PCR reactions were performed using TaqMan Universal PCR Master Mix 
(Applied Biosystems) according to manufacturer's instructions. The PCR reactions were 
performed on an ABS Prism 7000 Sequence Detection System (Applied Biosystems) and 
analysed using ABS Prism 7000 SDS software (Applied Biosystems). Fold change of gene 
transcription was calculated using the relative quantification method with rrsB endogenous 
control. The gene transcript abundance of cas, spy and sstorA–gfp in E. coli BW25113 wt cells 
harbouring pTG were used as calibrators. All PCR reactions were performed in triplicate.
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CHAPTER 6
PROSPECTIVE APPLICATIONS IN ENGINEERING EXTRACELLULAR SECRETION
6.0 Introduction
! The work presented in this dissertation challenges the status quo that non-pathogenic E. 
coli is a poor secretor of proteins. There is an increasing body of evidence presented here and in 
other studies that suggest that E. coli encodes secretory mechanisms capable of high-titer 
production of heterologous proteins in the extracellular medium. Perhaps the most outstanding of 
these secretory mechanisms is the YebF secretion pathway, which promoted much greater 
secretion than any of the other single-domain E. coli secretion systems such as OsmY, OmpF, 
and OmpA in our studies. Furthermore, the YebF pathway’s tolerance to secrete heterologous 
proteins with diverse functional and structural properties makes it a powerful tool for many 
biotechnology applications that benefit from or require extracellular biosynthesis of proteins, in 
particular consolidated bioprocessing which requires extracellular enzymes to deconstruct plant 
biomass. !
! Due in part to E. coli’s genetic tractability, we were able to reprogram cells for increased 
secretion levels of YebF by employing a FlAsH-based high-throughput screening platform. 
These engineered strains demonstrated increased secretion levels of both YebF and YebF-fusion 
proteins. In addition to the FlAsH-based screen, we engineered a genetic selection whereby the 
non-secretory phenotype was lethal, which further streamlines the identification of rare genetic 
events that effect secretion activity. Taken together, our new approach for engineering 
extracellular secretion pathways opens the door to creating superior expression hosts for the 
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extracellular biosynthesis of heterologous proteins. In this chapter, I will describe some future 
work that builds upon the tools developed in the previous chapters of this thesis. 
6.1 Cellulosomes
! Plant pathogens have evolved two common mechanisms to deconstruct plant biomass 
during host invasion. One mechanism is to secrete PCWDEs freely to the extracellular milieu, 
typically by T2SS or other secretory mechanism. Once secreted, these enzymes are no longer 
associated with the host cell, and this free-enzyme secretion strategy is typically employed by 
aerobic organisms. An alternative strategy, more commonly found in anaerobic bacteria such as 
Clostridium thermocellum, is to tether enzymes to the cell surface as large (megaDalton) 
extracellular complexes called cellulosomes. The assembly of cellulosomes on the cell surface 
offers distinct advantages over free-enzyme systems. For example, the cellulosome is 
sandwiched between the host cell and the plant biomass material, allowing easier access of 
released nutrients to the host. Another advantage is that cellulosomes give the host the ability to 
control the spatial organization of enzymes and their stoichiometry. The result is an enzyme 
channeling effect that can produce synergies among enzymes not normally achieved in free 
enzyme systems (Fontes and Gilbert, 2010; Delisa and Conrado, 2009). 
! The construction of cellulosomes centers on a non-cellulolytic scaffoldin that is anchored 
in the host outer membrane. The scaffoldin is decorated with cohesion domains, which have 
affinity for corresponding dockerin domains that are encoded in the cellulases, hemicellulases, 
and carbohydrate-bind modules (CBMs). The CBMs play a critical role in mediating protein-
carbohydrate interactions and targeting the catalytic domains of the cellulosome to the plant 
substrate (Fontes and Gilbert, 2010). The result is a highly modular cellulolytic complex 
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whereby catalytic enzymes are mounted on a non-catalytic scaffoldin via their dockerin-cohesion 
domains.  The modular nature of cellulosomes can be exploited in the laboratory to create small-
scale ‘designer’ cellulosomes. For example, engineered miniature cellulosomes have successfully 
been expressed in S. cervisiae (Hyeon et al., 2010; Tsai and Goyal, 2010) and also Bacillus 
subtilis (Anderson et al., 2011). Engineering mini-cellulosomes in these strains represents a step 
forward in engineering a consolidated bioprocessing microbe capable of high level ethanol 
production directly from plant biomass. 
! A requirement for the assembly of mini-cellulosomes is the extracellular production of 
cellulases that become mounted on surface-displayed scaffoldins. In a previous study, bacterial 
mini-cellulosomes were constructed by adding purified cellulases to scaffoldin-expressing cells, 
or by co-expressing the enzymes with the scaffoldin (Anderson et al., 2011). As a result, a large 
portion of protein (~70%) was not anchored to the cell wall (Anderson et al., 2011). An alternate 
strategy for assembling mini-cellulosomes is to target the cellulases for extracellular secretion 
using a dedicated secretion system to allow them to self-assemble on scaffoldins displayed on the 
cell exterior. A particularly attractive secretion system for this purpose is the YebF system. Our 
studies have shown that YebF is capable of carrying at least four different cellulase enzymes by a 
single-host (Fig. 3.1). It is also possible that high secretion levels are necessary to saturate the 
dockerin site(s) decorated on the scaffoldins. To address this issue, the secretion of YebF-
cellulase could be combined with a host that has been reprogrammed for hypersecretion of YebF 
proteins to achieve secretion titers suitable for efficient scaffoldin-mediated surface display of 
these enzymes. The E. coli strain BW25113 ∆nlpD is an attractive host for this purpose because 
it yielded a high level of YebF secretion by FlASH analysis (Fig. 3.3), and the integrity of its 
outer membrane did not appear to be compromised (Table 3.4). 
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6.2 Optimizing the secretion of specific POI
! In Chapter 4, we describe the establishment of an engineered genetic selection for 
studying extracellular secretion pathways. The selection functions by the activity of the BLIP 
protein which inhibits the β-lactamase enzyme in the periplasmic compartment. When BLIP is 
fused to a secretory protein, such as YebF, it is exported out of the periplasm and into the culture 
medium, and as a result cells are more resistant to β-lactam antibiotics. This gives rise to varying 
resistance phenotypes that can be exploited to screen large or multiple genetic libraries to 
identify rare genetic events that affect secretion efficiency. For example, a plasmid encoding the 
YebF-BLIP selection system can be transformed into a library of E. coli strains carrying non-
essential gene deletions (known as the Keio library) (Baba et al., 2006) to identify trans-acting 
genetic factors that influence export of the YebF-BLIP fusion protein. Furthermore, this 
resistance phenotype makes it possible to screen large genetic libraries that are typically needed 
in directed evolution experiments. Thus, it should be possible to reprogram the YebF secretion 
machinery by screening error-prone PCR libraries of the OmpF, OmpC, and OmpX proteins to 
identify variants with improved activity. !
!  These strategies are not limited only to the YebF-BLIP fusion. It should be possible to 
employ the same strategies for engineering the secretion of virtually any POI, such as cellulases 
or other heterologous proteins. This can be done my inserting the POI between the YebF-BLIP 
fusion to create a YebF-POI-BLIP construct. A YebF-POI-BLIP construct should in principle be 
amenable to screening the same libraries as described above with the YebF-BLIP construct. Thus, 
it would be interesting to compare the genetic mutations that are isolated with the YebF-BLIP 
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versus the YebF-POI-BLIP construct. This leads to the tantalizing possibility that there are 
common mutations that affect the secretion of all YebF-fusion proteins. 
6.3 Optimizing co-secretion from a single host
! Co-secretion of different proteins is required in some biomolecular engineering contexts. 
This is particularly true for the construction of cellulosomes in consolidated bioprocessing 
platforms because efficient deconstruction of plant biomass requires multiple cellulase enzymes 
with different activities (Liao et al., 2011). Our studies have made it possible to engineer a single 
host for co-secretion of more than one protein into the extracellular environment. Furthermore, 
we have uncovered a method for reprogramming these cells to enhance the co-secretion 
efficiency of multiple proteins together. There are two critical observations in Chapter 3 that can 
be exploited to enhance the simultaneous co-secretion of heterologous proteins. First, while the 
YebF pathway was known to efficiently carry heterologous proteins to the culture supernatant 
(Zhang et al., 2006), it was unknown whether the YebF pathway could accommodate the 
secretion of more than one protein from a single host. Our studies indicate that the YebF pathway 
can secrete at least four different proteins. This was evident by immunoblot analysis that showed 
the presence of YebF-Cel3A, YebF-Cel5B, YebF-Cel6A, and YebF-Cel9A in the culture 
supernatant when expressed from a single plasmid (Fig. 3.1b). The second observation is that 
cells secreting these four proteins can grow on M9 minimal medium containing CMC as a sole 
carbon source, and this growth phenotype minimally required YebF-Cel3A and YebF-Cel5B 
(Table 3.1.2). 
! These two observations combined can be exploited to reprogram cells for enhanced co-
secretion of more than one protein by a single host cell. For example, the viability phenotype on 
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CMC creates a powerful method for screening combinatorial libraries to identify rare genetic 
events that enhance the secretion of both YebF-Cel3A and YebF-Cel5B together. By selecting 
cell growth on CMC, genome-wide transposon insertion libraries can be screened in this system 
to find trans-acting factors that enhance the secretion of YebF-Cel3A and YebF-Cel5B together. 
Alternatively, error-prone PCR libraries can be created in the YebF domains of YebF-Cel3A and 
YebF-Cel5B to find variants that lead to higher secretion titers. It would be interesting to 
compare the genetic mutations that arise in engineering co-secretion of YebF-Cel3A and YebF-
Cel5B with the mutations that arise from screening transposon-insertion libraries using our 
YebF-FT system because these studies may lead to common mutations that enhance secretion of 
all proteins. Finally, it is possible that overexpression of YebF proteins can saturate the YebF 
secretion system. Thus, the YebF carrier domain can be swapped with other secretion domains, 
such as OsmY, to test whether these systems alone or in combination with YebF can enhance 
secretion efficiency. 
106
REFERENCES
Alaimo, C., Catrein, I., Morf, L., Marolda, C.L., Callewaert, N., Valvano, M.A., Feldman, M.F., 
and Aebi, M. (2006). Two distinct but interchangeable mechanisms for flipping of lipid-linked 
oligosaccharides. Embo J 25, 967–976.
Altaras, N.E., and Cameron, D.C. (1999). Metabolic engineering of a 1,2-propanediol pathway in 
Escherichia coli. Appl Environ Microbiol 65, 1180–1185.
Altaras, N.E., and Cameron, D.C. (2000). Enhanced production of (R)-1,2-propanediol by 
metabolically engineered Escherichia coli. Biotechnol Prog 16, 940–946.
Amann, E., and Brosius, J. (1985). "ATG vectors' for regulated high-level expression of cloned 
genes in Escherichia coli. Gene 40, 183–190.
Amann, E., Ochs, B., and Abel, K.J. (1988). Tightly regulated tac promoter vectors useful for the 
expression of unfused and fused proteins in Escherichia coli. Gene 69, 301–315.
Anderson, T.D., Robson, S.A., Jiang, X.W., Malmirchegini, G.R., Fierobe, H.-P., Lazazzera, 
B.A., and Clubb, R.T. (2011). Assembly of minicellulosomes on the surface of Bacillus subtilis. 
Appl Environ Microbiol 77, 4849–4858.
Apweiler, R., Hermjakob, H., and Sharon, N. (1999). On the frequency of protein glycosylation, 
as deduced from analysis of the SWISS-PROT database. Biochim. Biophys. Acta 1473, 4–8.
Baba, T., Ara, T., Hasegawa, M., Takai, Y., Okumura, Y., Baba, M., Datsenko, K.A., Tomita, M., 
Wanner, B.L., and Mori, H. (2006). Construction of Escherichia coli K-12 in-frame, single-gene 
knockout mutants: the Keio collection. Mol Syst Biol 2, 2006.0008–.
Baneyx, F., and Mujacic, M. (2004). Recombinant protein folding and misfolding in Escherichia 
coli. Nat Biotechnol 22, 1399–1408.
Baranova, N., and Nikaido, H. (2002). The baeSR two-component regulatory system activates 
transcription of the yegMNOB (mdtABCD) transporter gene cluster in Escherichia coli and 
increases its resistance to novobiocin and deoxycholate. J Bacteriol 184, 4168–4176.
Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., Romero, D.A., 
and Horvath, P. (2007). CRISPR provides acquired resistance against viruses in prokaryotes. 
Science 315, 1709–1712.
Ben-Dor, S., Esterman, N., Rubin, E., and Sharon, N. (2004). Biases and complex patterns in the 
residues flanking protein N-glycosylation sites. Glycobiology 14, 95–101.
Blocker, A.A., Komoriya, K.K., and Aizawa, S.-I.S. (2003). Type III secretion systems and 
bacterial flagella: insights into their function from structural similarities. Proc Natl Acad Sci 
USA 100, 3027–3030.
107
Bokinsky, G., Peralta-Yahya, P.P., George, A., Holmes, B.M., Steen, E.J., Dietrich, J., Soon Lee, 
T., Tullman-Ercek, D., Voigt, C.A., Simmons, B.A., et al. (2011). Synthesis of three advanced 
biofuels from ionic liquid-pretreated switchgrass using engineered Escherichia coli. Proc Natl 
Acad Sci USA 108, 19949–19954.
Bolotin, A., Quinquis, B., Renault, P., Sorokin, A., Ehrlich, S.D., Kulakauskas, S., Lapidus, A., 
Goltsman, E., Mazur, M., Pusch, G.D., et al. (2004). Complete sequence and comparative 
genome analysis of the dairy bacterium Streptococcus thermophilus. Nat Biotechnol 22, 1554–
1558.
Bos, M.P., Robert, V., and Tommassen, J. (2007). Biogenesis of the Gram-Negative Bacterial 
Outer Membrane. Annu Rev Microbiol 61, 191–214.
Bouley, J., Condemine, G., and Shevchik, V.E. (2001). The PDZ domain of OutC and the N-
terminal region of OutD determine the secretion specificity of the type II out pathway of Erwinia 
chrysanthemi. J Mol Biol 308, 205–219.
Boyd, A.P., Grosdent, N., Tötemeyer, S., Geuijen, C., Bleves, S., Iriarte, M., Lambermont, I., 
Octave, J.N., and Cornelis, G.R. (2000). Yersinia enterocolitica can deliver Yop proteins into a 
wide range of cell types: development of a delivery system for heterologous proteins. Eur. J. Cell 
Biol. 79, 659–671.
Brouns, S.J.J., Jore, M.M., Lundgren, M., Westra, E.R., Slijkhuis, R.J.H., Snijders, A.P.L., 
Dickman, M.J., Makarova, K.S., Koonin, E.V., and Van Der Oost, J. (2008). Small CRISPR 
RNAs guide antiviral defense in prokaryotes. Science 321, 960–964.
Carte, J., Wang, R., Li, H., Terns, R.M., and Terns, M.P. (2008). Cas6 is an endoribonuclease that 
generates guide RNAs for invader defense in prokaryotes. Genes Dev 22, 3489–3496.
Castanié, M.P., Bergès, H., Oreglia, J., Prère, M.F., and Fayet, O. (1997). A set of pBR322-
compatible plasmids allowing the testing of chaperone-assisted folding of proteins overexpressed 
in Escherichia coli. Anal Biochem 254, 150–152.
Chen, W., and Helenius, A. (2000). Role of ribosome and translocon complex during folding of 
influenza hemagglutinin in the endoplasmic reticulum of living cells. Mol. Biol. Cell 11, 765–
772.
Collins, C.H.C., Leadbetter, J.R.J., and Arnold, F.H.F. (2006). Dual selection enhances the 
signaling specificity of a variant of the quorum-sensing transcriptional activator LuxR. Nat 
Biotechnol 24, 708–712.
Cornelis, G.R. (2006). The type III secretion injectisome. Nat Rev Microbiol 4, 811–825.
Darwin, A.J. (2005). The phage-shock-protein response. Mol Microbiol 57, 621–628.
Datsenko, K.A., and Wanner, B.L. (2000). One-step inactivation of chromosomal genes in 
Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97, 6640–6645.
108
DeBoy, R.T., Mongodin, E.F., Fouts, D.E., Tailford, L.E., Khouri, H., Emerson, J.B., Mohamoud, 
Y., Watkins, K., Henrissat, B., Gilbert, H.J., et al. (2008). Insights into plant cell wall degradation 
from the genome sequence of the soil bacterium Cellvibrio japonicus. J Bacteriol 190, 5455–
5463.
DeLisa, M.P., and Bentley, W.E. (2002). Bacterial autoinduction: looking outside the cell for new 
metabolic engineering targets. Microb Cell Fact 1, 5.
Delisa, M.P., and Conrado, R.J. (2009). Synthetic metabolic pipelines. Nat Biotechnol 27, 728–
729.
DeLisa, M.P., Lee, P., Palmer, T., and Georgiou, G. (2004). Phage shock protein PspA of 
Escherichia coli relieves saturation of protein export via the Tat pathway. J Bacteriol 186, 366–
373.
DeLisa, M.P., Samuelson, P., Palmer, T., and Georgiou, G. (2002). Genetic analysis of the twin 
arginine translocator secretion pathway in bacteria. J Biol Chem 277, 29825–29831.
DeLisa, M.P., Tullman, D., and Georgiou, G. (2003). Folding quality control in the export of 
proteins by the bacterial twin-arginine translocation pathway. Proc Natl Acad Sci USA 100, 
6115–6120.
Deveau, H., Barrangou, R., Garneau, J.E., Labonté, J., Fremaux, C., Boyaval, P., Romero, D.A., 
Horvath, P., and Moineau, S. (2008). Phage response to CRISPR-encoded resistance in 
Streptococcus thermophilus. J Bacteriol 190, 1390–1400.
Díez-Villaseñor, C.C., Almendros, C.C., García-Martínez, J.J., and Mojica, F.J.M.F. (2010). 
Diversity of CRISPR loci in Escherichia coli. CORD Conference Proceedings 156, 1351–1361.
Donath, M.J., Dominguez, M.A., and Withers, S.T. (2011). Development of an automated 
platform for high-throughput P1-phage transduction of Escherichia coli. J Lab Autom 16, 141–
147.
Ellis, R.J., and Hartl, F.U. (1996). Protein folding in the cell: competing models of chaperonin 
function. Faseb J 10, 20–26.
Feldman, M.F., Wacker, M., Hernandez, M., Hitchen, P.G., Marolda, C.L., Kowarik, M., Morris, 
H.R., Dell, A., Valvano, M.A., and Aebi, M. (2005). Engineering N-linked protein glycosylation 
with diverse O antigen lipopolysaccharide structures in Escherichia coli. Proc Natl Acad Sci 
USA 102, 3016–3021.
Fernandez, S., Palmer, D.R., Simmons, M., Sun, P., Bisbing, J., McClain, S., Mani, S., Burgess, 
T., Gunther, V., and Sun, W. (2007). Potential role for Toll-like receptor 4 in mediating 
Escherichia coli maltose-binding protein activation of dendritic cells. Infect Immun 75, 1359–
1363.
109
Fisher, A.C., Haitjema, C.H., Guarino, C., Celik, E., Endicott, C.E., Reading, C.A., Merritt, J.H., 
Ptak, A.C., Zhang, S., and DeLisa, M.P. (2011). Production of secretory and extracellular N-
linked glycoproteins in Escherichia coli. Appl Environ Microbiol 77, 871–881.
Fisher, A.C., Kim, W., and DeLisa, M.P. (2006). Genetic selection for protein solubility enabled 
by the folding quality control feature of the twin-arginine translocation pathway. Protein Sci 15, 
449–458.
Fontes, C.M.G.A., and Gilbert, H.J. (2010). Cellulosomes: highly efficient nanomachines 
designed to deconstruct plant cell wall complex carbohydrates. Annu. Rev. Biochem. 79, 655–
681.
Francetic, O., and Pugsley, A.P. (1996). The cryptic general secretory pathway (gsp) operon of 
Escherichia coli K-12 encodes functional proteins. J Bacteriol 178, 3544–3549.
Francetic, O., Badaut, C., Rimsky, S., and Pugsley, A.P. (2000a). The ChiA (YheB) protein of 
Escherichia coli K-12 is an endochitinase whose gene is negatively controlled by the nucleoid-
structuring protein H-NS. Mol Microbiol 35, 1506–1517.
Francetic, O., Belin, D., Badaut, C., and Pugsley, A.P. (2000b). Expression of the endogenous 
type II secretion pathway in Escherichia coli leads to chitinase secretion. Embo J 19, 6697–6703.
Francisco, J.A., and Georgiou, G. (1994). The expression of recombinant proteins on the external 
surface of Escherichia coli. Biotechnological applications. Ann. N. Y. Acad. Sci. 745, 372–382.
Galán, J.E., and Collmer, A. (1999). Type III secretion machines: bacterial devices for protein 
delivery into host cells. Science 284, 1322–1328.
Gardner, J.G., and Keating, D.H. (2010). Requirement of the type II secretion system for 
utilization of cellulosic substrates by Cellvibrio japonicus. Appl Environ Microbiol 76, 5079–
5087.
Georgiou, G. (1988). Optimizing the Production of Recombinant Proteins in Microorganisms. 
Aiche J 34, 1233–1248.
Gottesman, S.S. (1996). Proteases and their targets in Escherichia coli. Genetics 30, 465–506.
Griffin, B.A., Adams, S.R., and Tsien, R.Y. (1998). Specific covalent labeling of recombinant 
protein molecules inside live cells. Science 281, 269–272.
Grissa, I., Vergnaud, G., and Pourcel, C. (2008). CRISPRcompar: a website to compare clustered 
regularly interspaced short palindromic repeats. Nucleic Acids Res 36, W145–W148.
Grissa, I.I., Vergnaud, G.G., and Pourcel, C.C. (2007). CRISPRFinder: a web tool to identify 
clustered regularly interspaced short palindromic repeats. CORD Conference Proceedings 35, 
W52–W57.
110
Haft, D.H., Selengut, J., Mongodin, E.F., and Nelson, K.E. (2005). A guild of 45 CRISPR-
associated (Cas) protein families and multiple CRISPR/Cas subtypes exist in prokaryotic 
genomes. PLoS Comp Biol 1, e60–e60.
Hale, C., Kleppe, K., Terns, R.M., and Terns, M.P. (2008). Prokaryotic silencing (psi)RNAs in 
Pyrococcus furiosus. RNA 14, 2572–2579.
Hale, C.R., Zhao, P., Olson, S., Duff, M.O., Graveley, B.R., Wells, L., Terns, R.M., and Terns, 
M.P. (2009). RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex. Cell 139, 
945–956.
Ham, J.H., Bauer, D.W., Fouts, D.E., and Collmer, A. (1998). A cloned Erwinia chrysanthemi 
Hrp (type III protein secretion) system functions in Escherichia coli to deliver Pseudomonas 
syringae Avr signals to plant cells and to secrete Avr proteins in culture. Proc Natl Acad Sci 
USA 95, 10206–10211.
Haurwitz, R.E.R., Jinek, M.M., Wiedenheft, B.B., Zhou, K.K., and Doudna, J.A.J. (2010). 
Sequence- and structure-specific RNA processing by a CRISPR endonuclease. CORD 
Conference Proceedings 329, 1355–1358.
He, S.Y., Lindeberg, M., Chatterjee, A.K., and Collmer, A. (1991). Cloned Erwinia chrysanthemi 
out genes enable Escherichia coli to selectively secrete a diverse family of heterologous proteins 
to its milieu. Proc Natl Acad Sci USA 88, 1079–1083.
Helenius, A., and Aebi, M. (2001). Intracellular functions of N-linked glycans. Science 291, 
2364–2369.
Helenius, A., and Aebi, M. (2004). Roles of N-linked glycans in the endoplasmic reticulum. 
Annu. Rev. Biochem. 73, 1019–1049.
Hirakawa, H., Inazumi, Y., Masaki, T., Hirata, T., and Yamaguchi, A. (2005). Indole induces the 
expression of multidrug exporter genes in Escherichia coli. Mol Microbiol 55, 1113–1126.
Hodgkinson, J.L., Horsley, A., Stabat, D., Simon, M., Johnson, S., da Fonseca, P.C.A., Morris, 
E.P., Wall, J.S., Lea, S.M., and Blocker, A.J. (2009). Three-dimensional reconstruction of the 
Shigella T3SS transmembrane regions reveals 12-fold symmetry and novel features throughout 
(vol 16, pg 477, 2009). Nature Structural & Molecular Biology 16
Hou, B., Frielingsdorf, S., and Klösgen, R.B. (2006). Unassisted membrane insertion as the 
initial step in DeltapH/Tat-dependent protein transport. J Mol Biol 355, 957–967.
Hyeon, J.-E., Yu, K.-O., Suh, D.J., Suh, Y.-W., Lee, S.E., Lee, J., and Han, S.O. (2010). 
Production of minicellulosomes from Clostridium cellulovorans for the fermentation of 
cellulosic ethanol using engineered recombinant Saccharomyces cerevisiae. Fems Microbiol Lett 
310, 39–47.
Ignatova, Z., and Gierasch, L.M. (2004). Monitoring protein stability and aggregation in vivo by 
real-time fluorescent labeling. Proc Natl Acad Sci USA 101, 523–528.
111
Jarboe, L.R., Grabar, T.B., Yomano, L.P., Shanmugan, K.T., and Ingram, L.O. (2007). 
Development of ethanologenic bacteria. Adv Biochem Eng Biot 108, 237–261.
Jeoh, T., Michener, W., Himmel, M.E., Decker, S.R., and Adney, W.S. (2008). Implications of 
cellobiohydrolase glycosylation for use in biomass conversion. Biotechnol Biofuels 1, 10.
Joung, J.K., Ramm, E.I., and Pabo, C.O. (2000). A bacterial two-hybrid selection system for 
studying protein-DNA and protein-protein interactions. Proc Natl Acad Sci USA 97, 7382–7387.
Jyot, J.J., Balloy, V.V., Jouvion, G.G., Verma, A.A., Touqui, L.L., Huerre, M.M., Chignard, 
M.M., and Ramphal, R.R. (2011). Type II secretion system of Pseudomonas aeruginosa: in vivo 
evidence of a significant role in death due to lung infection. J Infect Dis 203, 1369–1377.
Kazemi-Pour, N., Condemine, G., and Hugouvieux-Cotte-Pattat, N. (2004). The secretome of the 
plant pathogenic bacterium Erwinia chrysanthemi. Proteomics 4, 3177–3186.
Kelly, J., Jarrell, H., Millar, L., Tessier, L., Fiori, L.M., Lau, P.C., Allan, B., and Szymanski, 
C.M. (2006). Biosynthesis of the N-linked glycan in Campylobacter jejuni and addition onto 
protein through block transfer. J Bacteriol 188, 2427–2434.
Kim, J.-Y., Doody, A.M., Chen, D.J., Cremona, G.H., Shuler, M.L., Putnam, D., and DeLisa, 
M.P. (2008). Engineered Bacterial Outer Membrane Vesicles with Enhanced Functionality. J Mol 
Biol 380, 51–66.
Kim, J.-Y., Fogarty, E.A., Lu, F.J., Zhu, H., Wheelock, G.D., Henderson, L.A., and DeLisa, M.P. 
(2005). Twin-arginine translocation of active human tissue plasminogen activator in Escherichia 
coli. Appl Environ Microbiol 71, 8451–8459.
Kleanthous, C. (2010). Swimming against the tide: progress and challenges in our understanding 
of colicin translocation. Nat Rev Microbiol 8, 843–848.
Konjufca, V., Wanda, S.-Y., Jenkins, M.C., and Curtiss, R. (2006). A recombinant attenuated 
Salmonella enterica serovar Typhimurium vaccine encoding Eimeria acervulina antigen offers 
protection against E. acervulina challenge. Infect Immun 74, 6785–6796.
Korotkov, K.V., Sandkvist, M., and Hol, W.G.J. (2012). The type II secretion system: biogenesis, 
molecular architecture and mechanism. Nat Rev Microbiol 10, 336–351.
Kotzsch, A., Vernet, E., Hammarström, M., Berthelsen, J., Weigelt, J., Gräslund, S., and 
Sundström, M. (2011). A secretory system for bacterial production of high-profile protein targets. 
Protein Sci 20, 597–609.
Kowarik, M., Numao, S., Feldman, M.F., Schulz, B.L., Callewaert, N., Kiermaier, E., Catrein, I., 
and Aebi, M. (2006a). N-linked glycosylation of folded proteins by the bacterial 
oligosaccharyltransferase. Science 314, 1148–1150.
112
Kowarik, M., Young, N.M., Numao, S., Schulz, B.L., Hug, I., Callewaert, N., Mills, D.C., 
Watson, D.C., Hernandez, M., Kelly, J.F., et al. (2006b). Definition of the bacterial N-
glycosylation site consensus sequence. Embo J 25, 1957–1966.
Kumar, A., Hajjar, E., Ruggerone, P., and Ceccarelli, M. (2010). Structural and dynamical 
properties of the porins OmpF and OmpC: insights from molecular simulations. J. Phys.: 
Condens. Matter 22, 454125.
Kunin, V., Sorek, R., and Hugenholtz, P. (2007). Evolutionary conservation of sequence and 
secondary structures in CRISPR repeats. Genome Biol 8, R61–R61.
Laurent, N., Voglmeir, J., and Flitsch, S.L. (2008). Glycoarrays--tools for determining protein-
carbohydrate interactions and glycoenzyme specificity. Chem Commun (Camb) 4400–4412.
Liao, H., Zhang, X.-Z., Rollin, J.A., and Zhang, Y.-H.P. (2011). A minimal set of bacterial 
cellulases for consolidated bioprocessing of lignocellulose. Biotechnology Journal 6, 1409–1418.
Lillestøl, R.K., Shah, S.A., Brügger, K., Redder, P., Phan, H., Christiansen, J., and Garrett, R.A. 
(2009). CRISPR families of the crenarchaeal genus Sulfolobus: bidirectional transcription and 
dynamic properties. Mol Microbiol 72, 259–272.
Lindeberg, M. (1992). Analysis of eight out genes in a cluster required for pectic enzyme 
secretion by Erwinia chrysanthemi: sequence comparison with secretion genes from other gram- 
…. J Bacteriol.
Lindeberg, M., Salmond, G., and Collmer, A. (1996). Complementation of deletion mutations in 
a cloned functional cluster of Erwinia chrysanthemi out genes with Erwinia carotovora out 
homologues reveals OutC and OutD as candidate gatekeepers of species-specific secretion of 
proteins via the type II pathway. Mol Microbiol 20, 175–190.
Liu, J., Carmell, M.A., Rivas, F.V., Marsden, C.G., Thomson, J.M., Song, J.-J., Hammond, S.M., 
Joshua-Tor, L., and Hannon, G.J. (2004). Argonaute2 is the catalytic engine of mammalian 
RNAi. Science 305, 1437–1441.
Lodinová-Žádníková, R., Sonnenborn, U., and Tlaskalová, H. (1998). Probiotics and E. coli 
infections in man. Vet Q 20, 78–81.
Lynd, L.R., Laser, M.S., Bransby, D., Dale, B.E., Davison, B., Hamilton, R., Himmel, M., Keller, 
M., McMillan, J.D., Sheehan, J., et al. (2008). How biotech can transform biofuels. Nat 
Biotechnol 26, 169–172.
MacRitchie, D.M., Buelow, D.R., Price, N.L., and Raivio, T.L. (2008). Two-component signaling 
and gram negative envelope stress response systems. Adv. Exp. Med. Biol. 631, 80–110.
Makarova, K.S., Grishin, N.V., Shabalina, S.A., Wolf, Y.I., and Koonin, E.V. (2006). A putative 
RNA-interference-based immune system in prokaryotes: computational analysis of the predicted 
enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms 
of action. Biol. Direct 1, 7–7.
113
Malo, N., Hanley, J.A., Cerquozzi, S., Pelletier, J., and Nadon, R. (2006). Statistical practice in 
high-throughput screening data analysis. Nat Biotechnol 24, 167–175.
Mansell, T.J., Linderman, S.W., Fisher, A.C., and DeLisa, M.P. (2010). A rapid protein folding 
assay for the bacterial periplasm. Protein Sci 19, 1079–1090.
Marraffini, L.A., and Sontheimer, E.J. (2008). CRISPR interference limits horizontal gene 
transfer in staphylococci by targeting DNA. Science 322, 1843–1845.
Marraffini, L.A.L., and Sontheimer, E.J.E. (2010). Self versus non-self discrimination during 
CRISPR RNA-directed immunity. CORD Conference Proceedings 463, 568–571.
Martin, B.R., Giepmans, B.N.G., Adams, S.R., and Tsien, R.Y. (2005). Mammalian cell-based 
optimization of the biarsenical-binding tetracysteine motif for improved fluorescence and 
affinity. Nat Biotechnol 23, 1308–1314.
McBroom, A.J., Johnson, A.P., Vemulapalli, S., and Kuehn, M.J. (2006). Outer membrane 
vesicle production by Escherichia coli is independent of membrane instability. J Bacteriol 188, 
5385–5392.
Michaelis, S.S., Chapon, C.C., D'Enfert, C.C., Pugsley, A.P.A., and Schwartz, M.M. (1985). 
Characterization and expression of the structural gene for pullulanase, a maltose-inducible 
secreted protein of Klebsiella pneumoniae. J Bacteriol 164, 633–638.
Model, P., Jovanovic, G., and Dworkin, J. (1997). The Escherichia coli phage-shock-protein 
(psp) operon. Mol Microbiol 24, 255–261.
Nandakumar, M.P., Cheung, A., and Marten, M.R. (2006). Proteomic analysis of extracellular 
proteins from Escherichia coli W3110. 5, 1155–1161.
Ni, Y., and Chen, R. (2009). Extracellular recombinant protein production from Escherichia coli. 
Biotechnol Lett 31, 1661–1670.
Oresnik, I.J.I., Ladner, C.L.C., and Turner, R.J.R. (2001). Identification of a twin-arginine leader-
binding protein. Mol Microbiol 40, 323–331.
Paradkar, A.S., Aidoo, K.A., Wong, A., and Jensen, S.E. (1996). Molecular analysis of a beta-
lactam resistance gene encoded within the cephamycin gene cluster of Streptomyces 
clavuligerus. J Bacteriol 178, 6266–6274.
Perez-Rodriguez, R., Haitjema, C., Huang, Q., Nam, K.H., Bernardis, S., Ke, A., and DeLisa, 
M.P. (2011). Envelope stress is a trigger of CRISPR RNA-mediated DNA silencing in 
Escherichia coli. Mol Microbiol 79, 584–599.
Pérez-Melgosa, M., Ochs, H.D., Linsley, P.S., Laman, J.D., van Meurs, M., Flavell, R.A., Ernst, 
R.K., Miller, S.I., and Wilson, C.B. (2001). Carrier-mediated enhancement of cognate T cell 
help: the basis for enhanced immunogenicity of meningococcal outer membrane protein 
polysaccharide conjugate vaccine. Eur J Immunol 31, 2373–2381.
114
Pérez-Rodríguez, R., Fisher, A.C., Perlmutter, J.D., Hicks, M.G., Chanal, A., Santini, C.-L., Wu, 
L.-F., Palmer, T., and DeLisa, M.P. (2007). An essential role for the DnaK molecular chaperone 
in stabilizing over-expressed substrate proteins of the bacterial twin-arginine translocation 
pathway. J Mol Biol 367, 715–730.
Prehna, G., Zhang, G., Gong, X., Duszyk, M., Okon, M., McIntosh, L.P., Weiner, J.H., and 
Strynadka, N.C.J. (2012). A Protein Export Pathway Involving Escherichia coli Porins. 
Structure.
Pugsley, A.P. (1993). The complete general secretory pathway in gram-negative bacteria. 
Microbiol Rev 57, 50–108.
Pul, U., Wurm, R., Arslan, Z., Geissen, R., Hofmann, N., and Wagner, R. (2010). Identification 
and characterization of E. coli CRISPR-cas promoters and their silencing by H-NS. Mol 
Microbiol 75, 1495–1512.
Raffa, R.G., and Raivio, T.L. (2002). A third envelope stress signal transduction pathway in 
Escherichia coli. Mol Microbiol 45, 1599–1611.
Rao, S.S., Hu, S.S., McHugh, L.L., Lueders, K.K., Henry, K.K., Zhao, Q.Q., Fekete, R.A.R., 
Kar, S.S., Adhya, S.S., and Hamer, D.H.D. (2005). Toward a live microbial microbicide for HIV: 
commensal bacteria secreting an HIV fusion inhibitor peptide. Proc Natl Acad Sci USA 102, 
11993–11998.
Rüssmann, H., Shams, H., Poblete, F., Fu, Y., n, J.E.G., and Donis, R.O. (1998). Delivery of 
epitopes by the Salmonella type III secretion system for vaccine development. Science 281, 565–
568.
Rêgo, A.T., Chandran, V., and Waksman, G. (2010). Two-step and one-step secretion 
mechanisms in Gram-negative bacteria: contrasting the type IV secretion system and the 
chaperone-usher pathway of pilus biogenesis. Biochem J 425, 475–488.
Richter, S., and Brüser, T. (2005). Targeting of unfolded PhoA to the TAT translocon of 
Escherichia coli. J Biol Chem 280, 42723–42730.
Rinas, U., and Hoffmann, F. (2004). Selective leakage of host-cell proteins during high-cell-
density cultivation of recombinant and non-recombinant Escherichia coli. Biotechnol Prog 20, 
679–687.
Rogers, P.L., Jeon, Y.J., Lee, K.J., and Lawford, H.G. (2007). Zymomonas mobilis for fuel 
ethanol and higher value products. Adv Biochem Eng Biotechnol 108, 263–288.
Sanders, C., Wethkamp, N., and Lill, H. (2001). Transport of cytochrome c derivatives by the 
bacterial Tat protein translocation system. Mol Microbiol 41, 241–246.
Sandkvist, M., Michel, L.O., Hough, L.P., Morales, V.M., Bagdasarian, M., Koomey, M., DiRita, 
V.J., and Bagdasarian, M. (1997). General secretion pathway (eps) genes required for toxin 
secretion and outer membrane biogenesis in Vibrio cholerae. J Bacteriol 179, 6994–7003.
115
Smith, G.P. (1985). Filamentous fusion phage: novel expression vectors that display cloned 
antigens on the virion surface. Science 228, 1315–1317.
Sonti, R. (2005). Bacterial type two secretion system secreted proteins: Double-edged swords for 
plant pathogens. Mol Plant Microbe in 18, 891–898.
Sorek, R., Kunin, V., and Hugenholtz, P. (2008). CRISPR--a widespread system that provides 
acquired resistance against phages in bacteria and archaea. Nat Rev Microbiol 6, 181–186.
Stemmer, W.P. (1994). Rapid evolution of a protein in vitro by DNA shuffling. Nature 370, 389–
391.
Szymanski, C.M., and Wren, B.W. (2005). Protein glycosylation in bacterial mucosal pathogens. 
Nat Rev Microbiol 3, 225–237.
Szymanski, C.M., Yao, R., Ewing, C.P., Trust, T.J., and Guerry, P. (1999). Evidence for a system 
of general protein glycosylation in Campylobacter jejuni. Mol Microbiol 32, 1022–1030.
Takiff, H.E.H., Chen, S.M.S., and Court, D.L.D. (1989). Genetic analysis of the rnc operon of 
Escherichia coli. J Bacteriol 171, 2581–2590.
Tang, T.-H., Bachellerie, J.-P., Rozhdestvensky, T., Bortolin, M.-L., Huber, H., Drungowski, M., 
Elge, T., Brosius, J., and Hüttenhofer, A. (2002). Identification of 86 candidates for small non-
messenger RNAs from the archaeon Archaeoglobus fulgidus. Proc Natl Acad Sci USA 99, 7536–
7541.
Tauschek, M.M., Gorrell, R.J.R., Strugnell, R.A.R., and Robins-Browne, R.M.R. (2002). 
Identification of a protein secretory pathway for the secretion of heat-labile enterotoxin by an 
enterotoxigenic strain of Escherichia coli. Proc Natl Acad Sci USA 99, 7066–7071.
Tsai, S.-L., and Goyal, G. (2010). Surface display of a functional minicellulosome by 
intracellular complementation using a synthetic yeast consortium and its application to cellulose 
hydrolysis and ethanol production. Appl Environ Microbiol 76, 7514–7520.
Usón, I., Patzer, S.I., Rodríguez, D.D., Braun, V., and Zeth, K. (2012). The crystal structure of 
the dimeric colicin M immunity protein displays a 3D domain swap. J Struct Biol 178, 45–53.
Verez-Bencomo, V., Fernández-Santana, V., Hardy, E., Toledo, M.E., Rodríguez, M.C., 
Heynngnezz, L., Rodriguez, A., Baly, A., Herrera, L., Izquierdo, M., et al. (2004). A synthetic 
conjugate polysaccharide vaccine against Haemophilus influenzae type b. Science 305, 522–525.
Wacker, M., Linton, D., Hitchen, P.G., Nita-Lazar, M., Haslam, S.M., North, S.J., Panico, M., 
Morris, H.R., Dell, A., Wren, B.W., et al. (2002). N-linked glycosylation in Campylobacter jejuni 
and its functional transfer into E. coli. Science 298, 1790–1793.
Waraho, D., and DeLisa, M.P. (2009). Versatile selection technology for intracellular protein-
protein interactions mediated by a unique bacterial hitchhiker transport mechanism. Proc Natl 
Acad Sci USA 106, 3692–3697.
116
Waters, L.S., and Storz, G. (2009). Regulatory RNAs in Bacteria. Cell 136, 615–628.
Westendorf, A.M.A., Gunzer, F.F., Deppenmeier, S.S., Tapadar, D.D., Hunger, J.K.J., Schmidt, 
M.A.M., Buer, J.J., and Bruder, D.D. (2005). Intestinal immunity of Escherichia coli NISSLE 
1917: a safe carrier for therapeutic molecules. FEMS Immunol Med Microbiol 43, 373–384.
Westra, E.R., Pul, U., Heidrich, N., Jore, M.M., Lundgren, M., Stratmann, T., Wurm, R., Raine, 
A., Mescher, M., Van Heereveld, L., et al. (2010). H-NS-mediated repression of CRISPR-based 
immunity in Escherichia coli K12 can be relieved by the transcription activator LeuO. Mol 
Microbiol 77, 1380–1393.
Whitley, P.P., Nilsson, I.M.I., and Heijne, von, G.G. (1996). A nascent secretory protein may 
traverse the ribosome/endoplasmic reticulum translocase complex as an extended chain. J Biol 
Chem 271, 6241–6244.
Widmaier, D.M., Tullman-Ercek, D., Mirsky, E.A., Hill, R., Govindarajan, S., Minshull, J., and 
Voigt, C.A. (2009). Engineering the Salmonella type III secretion system to export spider silk 
monomers. Mol Syst Biol 5, 309–.
Wilson, D.B. (2009). Cellulases and biofuels. Curr Opin Biotechnol 20, 295–299.
Xia, X.-X., Han, M.-J., Lee, S.Y., and Yoo, J.-S. (2008). Comparison of the extracellular 
proteomes of Escherichia coli B and K-12 strains during high cell density cultivation. 
Proteomics 8, 2089–2103.
Yamamoto, K., Ogasawara, H., and Ishihama, A. (2008). Involvement of multiple transcription 
factors for metal-induced spy gene expression in Escherichia coli. J Biotechnol 133, 196–200.
You, L., and Arnold, F.H. (1996). Directed evolution of subtilisin E in Bacillus subtilis to 
enhance total activity in aqueous dimethylformamide. Protein Eng 9, 77–83.
Young, N.M.N., Brisson, J.-R.J., Kelly, J.J., Watson, D.C.D., Tessier, L.L., Lanthier, P.H.P., 
Jarrell, H.C.H., Cadotte, N.N., Michael, F.F.S., Aberg, E.E., et al. (2002). Structure of the N-
linked glycan present on multiple glycoproteins in the Gram-negative bacterium, Campylobacter 
jejuni. J Biol Chem 277, 42530–42539.
Zhang, G., Brokx, S., and Weiner, J. (2006). Extracellular accumulation of recombinant proteins 
fused to the carrier protein YebF in Escherichia coli. Nat Biotechnol 24, 100–104.
Zhang, Z., and Palzkill, T. (2003). Determinants of binding affinity and specificity for the 
interaction of TEM-1 and SME-1 beta-lactamase with beta-lactamase inhibitory protein. J Biol 
Chem 278, 45706–45712.
117
